<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="review-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell Dev. Biol.</journal-id>
<journal-title>Frontiers in Cell and Developmental Biology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell Dev. Biol.</abbrev-journal-title>
<issn pub-type="epub">2296-634X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1359152</article-id>
<article-id pub-id-type="doi">10.3389/fcell.2024.1359152</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cell and Developmental Biology</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Mitochondrial P-JNK target, SAB (SH3BP5), in regulation of cell death</article-title>
<alt-title alt-title-type="left-running-head">Win et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fcell.2024.1359152">10.3389/fcell.2024.1359152</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Win</surname>
<given-names>Sanda</given-names>
</name>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1234555/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Than</surname>
<given-names>Tin Aung</given-names>
</name>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2669526/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Kaplowitz</surname>
<given-names>Neil</given-names>
</name>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/335952/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
</contrib-group>
<aff>
<institution>Department of Medicine</institution>, <institution>Division of Gastroenterology and Liver Diseases</institution>, <institution>University of Southern California</institution>, <addr-line>Los Angeles</addr-line>, <addr-line>CA</addr-line>, <country>United States</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1800321/overview">Zhibin Zhang</ext-link>, University of Texas MD Anderson Cancer Center, United States</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/430857/overview">Jeremy W. Chambers</ext-link>, Florida International University, United States</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2628109/overview">Lu Yang</ext-link>, Tulane University, United States</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Sanda Win, <email>swin@usc.edu</email>; Neil Kaplowitz, <email>kaplowit@usc.edu</email>
</corresp>
<fn fn-type="other" id="fn1">
<label>
<sup>&#x2020;</sup>
</label>
<p>ORCID: Sanda Win, <ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0001-7694-5172">orcid.org/0000-0001-7694-5172</ext-link>; Tin Aung Than, <ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0001-8818-9271">orcid.org/0000-0001-8818-9271</ext-link>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>15</day>
<month>03</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>12</volume>
<elocation-id>1359152</elocation-id>
<history>
<date date-type="received">
<day>20</day>
<month>12</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>19</day>
<month>02</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Win, Than and Kaplowitz.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Win, Than and Kaplowitz</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Cell death occurs in various circumstances, such as homeostasis, stress response, and defense, <italic>via</italic> specific pathways and mechanisms that are regulated by specific activator-induced signal transductions. Among them, Jun N-terminal kinases (JNKs) participate in various aspects, and the recent discovery of JNKs and mitochondrial protein SAB interaction in signal regulation of cell death completes our understanding of the mechanism of sustained activation of JNK (P-JNK), which leads to triggering of the machinery of cell death. This understanding will lead the investigators to discover the modulators facilitating or preventing cell death for therapeutic application in acute or chronic diseases and cancer. We discuss here the mechanism and modulators of the JNK-SAB-ROS activation loop, which is the core component of mitochondria-dependent cell death, specifically apoptosis and mitochondrial permeability transition (MPT)-driven necrosis, and which may also contribute to cell death mechanisms of ferroptosis and pyroptosis. The discussion here is based on the results and evidence discovered from liver disease models, but the JNK-SAB-ROS activation loop to sustain JNK activation is universally applicable to various disease models where mitochondria and reactive oxygen species contribute to the mechanism of disease.</p>
</abstract>
<kwd-group>
<kwd>apoptosis</kwd>
<kwd>ferroptosis</kwd>
<kwd>necrosis</kwd>
<kwd>pyroptosis</kwd>
<kwd>SAB (SH3BP5)</kwd>
<kwd>Jun N-terminal kinase</kwd>
<kwd>JNK-SAB-ROS activation loop</kwd>
<kwd>SAB-KIM1 peptide</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Cell Death and Survival</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>Introduction</title>
<p>Mitochondrial-dependent regulated cell death was first described in apoptosis and mitochondrial permeability transition (MPT)-driven necrosis. Jun N-terminal kinases (JNKs) contribute as a key stress kinase to modulate intrinsic and extrinsic pathways of apoptotic cell death. Mammalian JNKs are expressed by three distinct genes, <italic>JNK1-3</italic>. Multiple splice variants form a family of kinases phosphorylating serine adjacent to the proline of target proteins in response to various forms of cellular and metabolic stress, growth factors, and inflammatory cytokines. JNK-interacting protein (JIP) provides a cytoplasmic platform for JNK docking at kinase-interacting motif (KIM) to interact and phosphorylate JNK-targeted proteins (<xref ref-type="bibr" rid="B48">Liu and Lin, 2005</xref>; <xref ref-type="bibr" rid="B16">Dhanasekaran and Reddy, 2008</xref>). JNK binding to mitochondrial scaffold protein SAB (SH3BP5) was first described in chick embryonic fibroblasts by co-localization of activated P-JNK and SAB in immuno-fluorescence staining (<xref ref-type="bibr" rid="B86">Wiltshire et al., 2008</xref>). Importantly, SAB is a key mediator in JNK regulation of mitochondrial-dependent cell death and was first described in numerous <italic>in vitro</italic> and <italic>in vivo</italic> models such as galactosamine (GalN)/tumor necrosis factor (TNF)&#x3b1;-induced apoptosis, lipotoxicity or endoplasmic reticulum (ER) stress-induced apoptosis, and acetaminophen-induced necrosis (<xref ref-type="bibr" rid="B90">Win et al., 2011</xref>; <xref ref-type="bibr" rid="B89">Win et al., 2014</xref>; <xref ref-type="bibr" rid="B93">Win et al., 2015</xref>). There are several additional modes of cell death which are categorized by the Nomenclature Committee on Cell Death (NCCD) in 2018 (<xref ref-type="bibr" rid="B24">Galluzzi et al., 2018</xref>). This review, however, focuses on modes of cell death which are specifically regulated by the interaction of JNK and outer mitochondrial membrane (OMM) protein SAB.</p>
</sec>
<sec id="s2">
<title>The pivotal role of SAB in JNK translocation to mitochondria</title>
<p>SAB, abbreviated from SH3 domain-binding protein that preferentially associates with Bruton&#x2019;s tyrosine kinase (BTK), was first identified in 1998 as a binding protein of the SH3 domain of BTK using Far-Western blotting. SAB was then cloned from a cDNA library made from the human placenta (<xref ref-type="bibr" rid="B54">Matsushita et al., 1998</xref>). Later, SAB was identified in yeast two-hybrid screening of human HeLa cell cDNA library using rat JNK3 as bait, and the SAB gene was officially named as SH3 domain-binding protein 5 (SH3BP5) in 2002 (<xref ref-type="bibr" rid="B86">Wiltshire et al., 2008</xref>). JNK, specifically activated JNK (P-JNK), binding of SAB was confirmed by GST pull-down assay of truncated expressed SAB protein. Sub-cellular localization of SAB on mitochondria was described in chick embryonic fibroblast by immuno-fluorescence staining of SAB, and it was found to co-localize with anisomycin-activated P-JNK on mitochondria (<xref ref-type="bibr" rid="B86">Wiltshire et al., 2008</xref>). One SAB gene expresses two splice variants: longer transcript isoform (a) and shorter transcript isoform (b). Two independent investigators simultaneously uncovered the functional role of SAB in JNK-mediated regulation of cell death in 2011 (<xref ref-type="bibr" rid="B8">Chambers and LoGrasso, 2011</xref>; <xref ref-type="bibr" rid="B90">Win et al., 2011</xref>). Subsequently, many investigators have found JNK translocation to mitochondria when JNK is activated, and mounting evidence has indicated that SAB is the only JNK docking protein on mitochondria. Adenoviral shRNA-mediated depletion of SAB in the liver completely inhibits P-JNK translocation to mitochondria (<xref ref-type="bibr" rid="B90">Win et al., 2011</xref>). The level of mitochondrial residence protein SAB directly correlates to the level of translocated P-JNK on mitochondria (<xref ref-type="bibr" rid="B87">Win et al., 2019</xref>). Intriguingly, p38 and P-p38 localization and level of mitochondria are independent of SAB expression (<xref ref-type="bibr" rid="B103">Zhang et al., 2017</xref>). Moreover, SAB does not directly associate and interact with MAP2Ks (MKK4 and 7) and MAP3Ks (<xref ref-type="bibr" rid="B103">Zhang et al., 2017</xref>). Differential expression of SAB in adult male and female mice and humans was reported, and mitochondria from female mice have decreased P-JNK translocation because of low levels of SAB protein. Increased expression of SAB causes more P-JNK translocation (<xref ref-type="bibr" rid="B87">Win et al., 2019</xref>). In addition to previous studies, subcellular fractionation of the liver confirmed that SAB is almost exclusively in mitochondria fraction but not in ER, cytosol, and nuclear fraction. Notably, the subcellular distribution of SAB does not change during toxic stress conditions (<xref ref-type="bibr" rid="B90">Win et al., 2011</xref>). Importantly, the overexpression of human and mouse SAB confirmed the mitochondrial localization of SAB (<xref ref-type="bibr" rid="B87">Win et al., 2019</xref>). SAB resides in the OMM as confirmed by the proteinase K digestion assay. Using N-terminal- and C-terminal-specific SAB antibodies, the N-terminus of SAB is found exposed to the intermembrane space, whereas the C-terminus of SAB is exposed to the cytoplasm (<xref ref-type="fig" rid="F1">Figure 1</xref>). One membrane-spanning domain was predicted (<xref ref-type="bibr" rid="B94">Win et al., 2016</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Topology of SAB and SAB regulation of apoptosis or necrosis <italic>via</italic> mitochondrial ROS production and sustained P-JNK. Topology of SAB is depicted in the figure. SAB is located at the outer mitochondrial membrane (OMM) with one membrane-spanning sequence. C-terminus of SAB is facing the cytoplasm and has JNK-docking motif (KIM2, dark orange) and JNK phosphorylation sites. N-terminus of SAB is facing the intermembrane space and has the SH3 domain-binding sequence (light orange) which may harbor PTPN6. Stress-induced activated JNK (P-JNK) binding and phosphorylation of OMM protein SAB lead to the release of intramitochondrial protein tyrosine phosphatase PTPN6, which then translocates to inner mitochondrial protein DOK4 where active P-Src is dephosphorylated and inactivated by PTPN6. Activated P-Src maintains the mitochondrial electron transport chain (ETC) activity, and dephosphorylation of Src decreases ETC and increases ROS production, which upregulates ASK1 activation and then MAP2K and JNK activation. The JNK-SAB-ROS feed forward activation loop sustains the JNK activation and incrementally increases ROS production, leading to apoptosis via outer mitochondrial membrane permeabilization (OMMP) or necrosis via increased mitochondrial permeability transition (MPT) depending on the nature of the specific cell death inducer.</p>
</caption>
<graphic xlink:href="fcell-12-1359152-g001.tif"/>
</fig>
<p>The N-terminus of SAB is speculated to have four coiled-coil domains, and SAB is a homolog of Ras-related GTP-binding protein Rab11 (RAB-11)-interacting protein-1 (REI-1) and a guanine nucleotide exchange factor (GEF) of <italic>Citrobacter elegans</italic>; however, both SAB and REI-1 do not contain any known Rab-GEF domain. REI-1 is expressed in <italic>C. elegans</italic> germline and co-localizes with small guanosine triphosphate hydrolase (GTPases) RAB-11 on the late-Golgi membranes (<xref ref-type="bibr" rid="B70">Sakaguchi et al., 2015</xref>; <xref ref-type="bibr" rid="B69">Sakaguchi et al., 2016</xref>; <xref ref-type="bibr" rid="B72">Sato et al., 2016</xref>). Given this, the structural analysis revealed the Rab-11 binding site on both helix &#x3b1;1 and &#x3b1;4 of murine SH3BP5 and REI-1 of <italic>C. elegans</italic> (<xref ref-type="bibr" rid="B37">Jenkins et al., 2018</xref>). Recently, co-localization of SAB, RAB-11, and lysosome marker Lamp1 in HeLa cells was described, but SAB and RAB-11 co-localization is much greater than Lamp1 distribution (<xref ref-type="bibr" rid="B26">Goto-Ito et al., 2019</xref>) because SAB is overwhelmingly found in the OMM. Overall, these results implied that the regulation of RAB-11 by SAB in the context of JNK-mediated cell death is an intriguing view that deserves further investigation. The C-terminus of SAB exposed to cytoplasm has a JNK docking site, referred to as KIM2, and serine phosphorylation sites. The other predicted docking site KIM1 is submerged in the mitochondrial membrane, and the coiled-coil region of SAB is predicted to lie in the intermembrane space (<xref ref-type="bibr" rid="B94">Win et al., 2016</xref>). With these various aspects, there is plenty of area of research to explicitly illuminate how SAB participates in small GTPase regulation of mitochondrial membrane transport and morphology in JNK-mediated cell deaths.</p>
</sec>
<sec id="s3">
<title>Crucial role of SAB in sustained activation of JNK</title>
<p>JNK is activated by numerous conditions of organelles, cellular and metabolic stress/injury, and growth and proliferation conditions. Importantly, JNK-mediated cell death is directly correlated with the sustained activation mechanism of JNK (<xref ref-type="bibr" rid="B16">Dhanasekaran and Reddy, 2008</xref>). Through the mitogen-activated protein kinase (MAPK) cascade, JNK, which is one of two MAPKs, is phospho-activated by MAP2K, MKK4, and MKK7, which are regulated by MAP3K such as apoptosis signal-regulating kinase 1 (ASK1), mixed lineage kinases (MLKs), and transforming growth factor-&#x3b2; (TGF-&#x3b2;)-activated kinase 1 (TAK1). Subcellular localization and structurally associated proteins determine the activation of MAP3K in various cellular conditions. Numerous pieces of evidence suggest that ASK1 and MLKs predominantly contribute to the sustained activation of JNK. The structure of ASK1 defines the role in the redox activation of JNK. ASK1 has a kinase domain at the center and one coiled-coil domain on either side of the kinase domain. The N-terminal domain is associated with thioredoxin and TNF receptor-associated factors (TRAFs) (<xref ref-type="bibr" rid="B84">Weijman et al., 2017</xref>). The C-terminus of ASK1 has a 14-3-3 binding site (<xref ref-type="bibr" rid="B14">Cockrell et al., 2010</xref>), followed by a constitutive oligomerization region. ASK1 is silent when homo-oligomerization occurs through the C-terminal coiled-coil region in non-stress conditions (<xref ref-type="bibr" rid="B39">Kawarazaki et al., 2014</xref>). Dissociation of thioredoxin from ASK1 under oxidative stress leads to the association of ASK1 and TRAF, leading to oligomerization of N-terminus and activation of ASK1 through autophosphorylation of Thr845 located in the kinase domain (<xref ref-type="bibr" rid="B5">Cebula et al., 2015</xref>). Since mitochondrial thioredoxin-2 has been identified, mitochondrial localization of ASK1 was proposed, but further investigations are required (<xref ref-type="bibr" rid="B105">Zhang et al., 2004</xref>). ASK1 protein itself is degraded in oxidative stress <italic>via</italic> ubiquitination, and inhibition of ubiquitination or facilitating de-ubiquitination stabilizes the ASK1 activity (<xref ref-type="bibr" rid="B59">Nagai et al., 2009</xref>). In addition, ASK1 activity is well regulated by cellular FLICE-like inhibitory protein (cFLIP), which competitively inhibits TRAF binding to ASK1 and prevents ASK1 dimerization and activation (<xref ref-type="bibr" rid="B82">Wang et al., 2017a</xref>). However, degradation of cFLIP is mediated by ubiquitination by itchy E3 ubiquitin protein ligase (ITCH,) which is activated by JNK (<xref ref-type="bibr" rid="B13">Chang et al., 2006</xref>). Recent evidence suggests that caspase recruitment domain protein 6 (CARD6) suppresses ASK1 phospho-activation but not TAK1, indicating the selectivity of regulation (<xref ref-type="bibr" rid="B67">Qin et al., 2018</xref>). TAK1 is phosphorylated and activated <italic>via</italic> the TLR/IL1 receptor and TRAFs, leading to the activation of NF-&#x3ba;B and JNK <italic>via</italic> IKK and MAP2K, respectively (<xref ref-type="bibr" rid="B79">Takaesu et al., 2001</xref>). Hepatocyte-specific deletion of TAK1 is lethal, suggesting the hepatoprotective role of TAK1 (<xref ref-type="bibr" rid="B36">Inokuchi et al., 2010</xref>), although further exploration is required. MLKs are regulated by small GTPases, CDC42 and RAC1 (<xref ref-type="bibr" rid="B42">Kelkar et al., 2005</xref>). Signal integration of SRC tyrosine kinase, RAC GTPase, and MLKs on the JIP1 platform activates MKK7 and JNK in mouse embryonic fibroblast (MEF) cells (<xref ref-type="bibr" rid="B57">Morel et al., 2010</xref>). JIP is known as a JNK-specific scaffold protein, and the pathway selectively activates JNK but not p38.</p>
<p>The increased understanding of the regulation of MAP3K activation enables us to construct the mechanism of sustained activation of JNK depending on the context. <italic>In vivo</italic> GalN/TNF&#x3b1; or <italic>in vitro</italic> ActD/TNF&#x3b1; induced apoptosis; initial receptor-mediated activation of ASK1 and JNK is sustained when the antioxidant system is blocked by GalN or ActD. Furthermore, deletion of SAB completely prevents sustained activation of JNK and cell death, suggesting the crucial role of SAB to sustain JNK activation (<xref ref-type="bibr" rid="B90">Win et al., 2011</xref>). Of note, depletion of mitochondrial SAB does not interfere with the initial activation of JNK such as receptor-mediated activation by ASK1 or JIP-mediated activation by MLKs. A compelling body of evidence indicates that the JNK-ITCH-ASK1 signal activation axis does not have an effect in contexts where SAB is deleted because depletion of SAB or MKK4/7 completely prevents TNF&#x3b1;-induced JNK activation and cell death, indicating the requirement of MAP2K, JNK, and SAB to sustain ASK1 and JNK activation (<xref ref-type="fig" rid="F1">Figure 1</xref>) (<xref ref-type="bibr" rid="B90">Win et al., 2011</xref>; <xref ref-type="bibr" rid="B94">Win et al., 2016</xref>; <xref ref-type="bibr" rid="B103">Zhang et al., 2017</xref>). Furthermore, SAB contributes a primary role in the sustained activation of JNK in lipotoxicity, ER stress-induced apoptosis, and acetaminophen-induced necrosis, which we discuss below (<xref ref-type="bibr" rid="B90">Win et al., 2011</xref>; <xref ref-type="bibr" rid="B89">Win et al., 2014</xref>; <xref ref-type="bibr" rid="B93">Win et al., 2015</xref>; <xref ref-type="bibr" rid="B94">Win et al., 2016</xref>; <xref ref-type="bibr" rid="B87">Win et al., 2019</xref>).</p>
</sec>
<sec id="s4">
<title>Essential role of SAB and JNK interaction in mitochondrial superoxide production</title>
<p>Mitochondria produce superoxide generated by electrons leaking from the electron transfer system located in the inner membrane of mitochondria. Production of mitochondrial superoxide in a cell is much more abundant than that in other systems such as xanthine oxidase and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase. Superoxide generated from mitochondria is a major cause of cellular oxidative damage (<xref ref-type="bibr" rid="B3">Brand et al., 2004</xref>). Until recently discovered by <xref ref-type="bibr" rid="B94">Win et al. (2016</xref>), there has been a knowledge gap in understanding how stress-induced JNK activation upregulates superoxide production from mitochondria. Stress-induced JNK activation causes translocation and binding of P-JNK to OMM protein SAB. P-JNK binds to the JNK docking site (KIM2) located at the C-terminus of SAB which is exposed to the cytoplasm. Mutation of the KIM2 sequence completely prevents P-JNK translocation and binding to mitochondria. SAB is also a substrate of JNK and presumably phosphorylated at serine 421 (human) or serine 424 (mouse) in the C-terminus facing the cytoplasm; mutation of this serine completely prevents the JNK activation-mediated liver injury in GalN/TNF&#x3b1; and acetaminophen hepatotoxicity. Therefore, SAB and P-JNK interaction on the OMM is the essential initial step for the production of superoxide from mitochondria. Activated P-JNK only binds to SAB, and P-JNK does not enter the mitochondria. Under basal conditions, the N-terminus of SAB including the SH3-domain-binding site which is exposed to the intermembrane space is associated with protein tyrosine phosphatase non-receptor type 6 (PTPN6/SHP1). SAB then releases PTPN6 when P-JNK binds and phosphorylates the C-terminus of SAB. Tyrosine-protein kinase c-SRC, mainly in the active form P-419-SRC, is inside mitochondria and is required to maintain the function of the electron transport chain (<xref ref-type="bibr" rid="B71">Salvi et al., 2002</xref>; <xref ref-type="bibr" rid="B56">Miyazaki et al., 2003</xref>; <xref ref-type="bibr" rid="B80">Tibaldi et al., 2008</xref>; <xref ref-type="bibr" rid="B23">Foster et al., 2009</xref>; <xref ref-type="bibr" rid="B61">Ogura et al., 2012</xref>). PTPN6 release from SAB leads to dephosphorylation of activated P-419-Src, which occurs on and requires the platform, docking protein 4 (DOK4), located on the mitochondrial inner membrane (<xref ref-type="fig" rid="F1">Figure 1</xref>) (<xref ref-type="bibr" rid="B94">Win et al., 2016</xref>). Decreased P-Src inhibits mitochondrial respiration and enhances reactive oxygen species (ROS) production (<xref ref-type="bibr" rid="B89">Win et al., 2014</xref>). One can speculate that when the translocation of P-JNK to mitochondria is little, such as in postprandial hepatocytes, the recovery of mitochondrial respiration is faster and thus ROS production reduces. Conclusively, the KIM1 peptide completely blocks the interaction of SAB and JNK, and prevents superoxide production from mitochondria and cell death (<xref ref-type="bibr" rid="B6">Chambers et al., 2011a</xref>; <xref ref-type="bibr" rid="B8">Chambers and LoGrasso, 2011</xref>; <xref ref-type="bibr" rid="B89">Win et al., 2014</xref>). SAB functions similarly to a membrane receptor which transduces the P-JNK effect on the surface of mitochondria to signal transduction inside the mitochondria.</p>
</sec>
<sec id="s5">
<title>SAB is a key mediator in mitochondrial-dependent cell death</title>
<sec id="s5-1">
<title>SAB regulation of apoptosis and necrosis</title>
<p>To explicitly illuminate the critical contribution of JNK and SAB interaction, and how interaction leads to sustaining JNK activation and regulation of apoptosis and necrosis, Win et al. examined the chronological and spatial changes of JNK in GalN/TNF&#x3b1; or ActD/TNF&#x3b1;-induced extrinsic-apoptosis model, lipotoxicity or ER stress-induced intrinsic-apoptosis model, and acetaminophen-induced MPT-driven necrosis model (<xref ref-type="bibr" rid="B90">Win et al., 2011</xref>; <xref ref-type="bibr" rid="B89">Win et al., 2014</xref>; <xref ref-type="bibr" rid="B93">Win et al., 2015</xref>; <xref ref-type="bibr" rid="B94">Win et al., 2016</xref>; <xref ref-type="bibr" rid="B103">Zhang et al., 2017</xref>; <xref ref-type="bibr" rid="B87">Win et al., 2019</xref>). In these various models of apoptotic and necrotic modes of cell death, it all starts with initial JNK activation, and the primary role of SAB is to increase mitochondrial superoxide production, resulting in sustained activation of JNK (P-JNK) leading to the activation of stress-inducer-specific cell death machinery such as modulating activity or expression of Bcl2 family proteins in TNF&#x3b1;-induced apoptosis, transcriptional upregulation of p53-upregulated modulator of apoptosis (PUMA) in lipotoxicity, Ca<sup>2&#x2b;</sup> influx to mitochondria in tunicamycin-induced cell death, massive depletion of glutathione (GSH), and the burst of ROS in a narrow time frame followed by the collapse of mitochondrial bioenergetics due to mitochondrial permeability transition pore (MPTP) in acetaminophen-induced necrosis. Therefore, the effect of unique biochemical properties of stress-inducers must be considered in modeling the regulation of the cell death mechanism.</p>
<p>Initial JNK activation: JNK is a stress-responsive kinase and is activated in all bio-physical-chemical changes of cell and cellular environment <italic>in vitro</italic> or <italic>in vivo</italic>; however, JNK kinase activity including P-JNK may be undetectable in physiological circumstances because of its transient nature and weak activity. Initial JNK activation occurs when a stress-inducer first interacts with the cell: TNF&#x3b1; engagement to the death receptor activates JNK in 5&#x2013;10 min and diminishes rapidly in 30 min (<xref ref-type="bibr" rid="B90">Win et al., 2011</xref>), exposure of free fatty acid to the cell membrane activates membrane-associated c-Src and then JNK is activated transiently and detected with the kinase assay (<xref ref-type="bibr" rid="B31">Holzer et al., 2011</xref>), the non-lethal dose of tunicamycin-induced ER stress activates JNK in 5&#x2013;10 min and diminishes quickly in 30 min (<xref ref-type="bibr" rid="B4">Brown et al., 2016</xref>), the first kinase of MAPK cascade activated by acetaminophen is MLKs, and non-lethal dose (150&#xa0;mg/kg i.p) of acetaminophen activates cytosol JNK in 15&#x2013;30 min and diminishes in an hour (<xref ref-type="bibr" rid="B73">Sharma et al., 2012</xref>). Thus, initially activated P-JNK becomes sustained and higher when P-JNK translocates and interacts with mitochondrial SAB.</p>
<p>Sustained JNK activation <italic>via</italic> the JNK-SAB-ROS activation loop: A mitochondrion is a complete hub where ROS is produced, and where MAPK cascade gathers to amplify and sustain JNK activation. We discuss here the principle of the mechanism (<xref ref-type="fig" rid="F1">Figure 1</xref>) of sustained activation of JNK using acetaminophen and GalN/TNF&#x3b1; model because of the detailed examination of numerous independent investigators in the field. Initial activated P-JNK translocates to mitochondria where P-JNK binds and phosphorylates SAB. P-JNK co-immunoprecipitated with SAB shortly after toxic stress before the liver injury occurred (<xref ref-type="bibr" rid="B90">Win et al., 2011</xref>; <xref ref-type="bibr" rid="B49">Liu et al., 2015</xref>; <xref ref-type="bibr" rid="B30">Heslop et al., 2020</xref>). This is further supported by the finding that knockdown of <italic>SAB</italic> prevented JNK translocation to mitochondria, inhibited sustained activation of JNK, and protected cell death <italic>in vitro</italic> and <italic>in vivo</italic> models (<xref ref-type="bibr" rid="B90">Win et al., 2011</xref>; <xref ref-type="bibr" rid="B89">Win et al., 2014</xref>; <xref ref-type="bibr" rid="B93">Win et al., 2015</xref>). Furthermore, hepatocyte-specific deletion of <italic>SAB via</italic> the delivery of AAV8-TBG-Cre to <italic>SAB</italic>-floxed mice or delivery of tamoxifen to <italic>SAB</italic>-floxed mice crossed with transgenic tamoxifen-inducible Alb-Cre mice completely protects against hepatic apoptosis or necrosis in those models. The depletion of SAB completely prevents translocation of JNK to mitochondria, suggesting that SAB is the only identifiable JNK docking mitochondrial-resident protein (<xref ref-type="bibr" rid="B94">Win et al., 2016</xref>). The depletion of SAB does not inhibit the association of mitochondria and p38 (<xref ref-type="bibr" rid="B103">Zhang et al., 2017</xref>); however, there is a report showing the phosphorylation of SAB by JNK and p38 in a cell-free system (<xref ref-type="bibr" rid="B15">Court et al., 2004</xref>). The topology and structure of SAB were revealed recently by several investigators (<xref ref-type="bibr" rid="B94">Win et al., 2016</xref>; <xref ref-type="bibr" rid="B37">Jenkins et al., 2018</xref>). The N-terminus of SAB facing intermembrane space has four coiled-coil domains and an SH3-domain-binding domain. The C-terminus of SAB faces the cytoplasm and contains two kinase-interacting motifs (KIMs) where JNK docks to its substrates. One membrane-spanning sequence is predicted, and only the shorter C-terminus of SAB exposed to the cytoplasm is removed in the proteinase K digestion assay, implying that longer N-terminus of SAB is intramitochondrial. Exposure of isolated mitochondria with P-JNK dose-dependently inhibits mitochondria respiration and decreases activated Src (P-419-Src) in mitochondria, but these did not occur in mitochondria from the SAB knockout liver. P-JNK inhibition of respiration was prevented by the KIM-blocking peptide (<xref ref-type="bibr" rid="B89">Win et al., 2014</xref>; <xref ref-type="bibr" rid="B93">Win et al., 2015</xref>; <xref ref-type="bibr" rid="B94">Win et al., 2016</xref>). P-419-Src is required to maintain the activity of the electron transport chain (<xref ref-type="bibr" rid="B71">Salvi et al., 2002</xref>; <xref ref-type="bibr" rid="B56">Miyazaki et al., 2003</xref>; <xref ref-type="bibr" rid="B80">Tibaldi et al., 2008</xref>; <xref ref-type="bibr" rid="B23">Foster et al., 2009</xref>; <xref ref-type="bibr" rid="B61">Ogura et al., 2012</xref>). Inactivation of mitochondria Src occurred in both apoptosis (TNF/GalN) and necrosis (APAP) models. Further investigation revealed that P-JNK binding and phosphorylation to SAB cause a release of protein tyrosine phosphatase non-receptor type 6 (PTPN6/SHP1), which is associated at the N-terminus of SAB, leading to dephosphorylation of activated Src on the DOK4 platform. DOK4 is found exclusively in the mitochondria fraction and is associated with the inner mitochondrial membrane (IMM). Knockdown of PTPN6 or DOK4 does not affect SAB levels but phenocopies the effects of SAB knockdown or knockout in hepatocyte response to stress (<xref ref-type="bibr" rid="B94">Win et al., 2016</xref>).</p>
<p>The next crucial step is the effect of the interaction of P-JNK with SAB on mitochondrial ROS production. Using isolated normal liver mitochondria, exposure of recombinant P-JNK1 and/or 2 leads to the inhibition of oxidative phosphorylation and maximum respiratory capacity, and production of superoxide in the presence but not in the absence of ATP, suggesting that phosphorylation of SAB was required. Because ROS production was inhibited in liver mitochondria isolated from SAB knockout mice or normal mitochondria treated with KIM1 peptide which blocks JNK and SAB interaction, SAB is required for mitochondrial ROS production (<xref ref-type="bibr" rid="B89">Win et al., 2014</xref>; <xref ref-type="bibr" rid="B93">Win et al., 2015</xref>; <xref ref-type="bibr" rid="B94">Win et al., 2016</xref>; <xref ref-type="bibr" rid="B35">Huo et al., 2017</xref>). ROS production is facilitated in ER stress due to Ca<sup>2&#x2b;</sup> influx which upregulates mitochondrial metabolism and NADH production (<xref ref-type="bibr" rid="B89">Win et al., 2014</xref>).</p>
<p>Released ROS oxidizes thioredoxin-relieving inhibition of ASK1 dimerization. Facilitating ASK1 N-terminal dimerization allows self-activation of ASK1 (<xref ref-type="bibr" rid="B104">Zhang et al., 2018</xref>). Activated ASK1 activates MKK4/7, which then activates JNKs (<xref ref-type="bibr" rid="B102">Zeke et al., 2016</xref>; <xref ref-type="bibr" rid="B95">Win et al., 2018a</xref>; <xref ref-type="bibr" rid="B91">Win et al., 2018b</xref>). MLKs are also activated by ROS <italic>via</italic> the activation of plasma membrane-associated Src. Depletion of ASK1 or MLK2/3 completely prevents sustained activation of JNK and APAP-induced liver necrosis. Furthermore, P-MKK4 is associated with mitochondrial P-JNK (<xref ref-type="bibr" rid="B103">Zhang et al., 2017</xref>). Depletion or inhibition of MLK2/3 prevents initial JNK activation in APAP toxicity but deletion or inhibition of ASK1, MKK4, or SAB does not, suggesting that MLK2/3 is the first MAP3K activated, and ASK1, MKK4, and SAB are involved in sustained activation of JNK (<xref ref-type="bibr" rid="B81">Urano et al., 2000</xref>; <xref ref-type="bibr" rid="B46">Liang et al., 2006</xref>; <xref ref-type="bibr" rid="B31">Holzer et al., 2011</xref>; <xref ref-type="bibr" rid="B90">Win et al., 2011</xref>; <xref ref-type="bibr" rid="B64">Papa et al., 2019</xref>). Therefore, the feed-forward activation of sustained JNK activation occurs through the ASK1-MKK4-JNK-SAB-ROS activation loop (<xref ref-type="fig" rid="F1">Figure 1</xref>), which is a key player in the mechanism of cellular stress and damage (<xref ref-type="bibr" rid="B94">Win et al., 2016</xref>; <xref ref-type="bibr" rid="B95">Win et al., 2018a</xref>).</p>
<p>The duration and degree of sustained JNK activation mediate many consequences, both through upregulation of activating protein-1 (AP-1) targets (<xref ref-type="bibr" rid="B95">Win et al., 2018a</xref>) involved in the proliferation; inflammation (production of cytokines and chemokines); metabolic gene dysregulation, for example, gene repressors, such as NCOR1 suppression on peroxisome proliferator-activated receptor alpha (PPAR&#x3b1;) and thioredoxin-disulfide reductase (TR); or enhanced apoptosis through the direct activation of proapoptotic protein BAX, and inhibition of anti-apoptotic Bcl2 family members such as Bcl-X<sub>L</sub>, Bcl2, or Mcl-1.</p>
</sec>
<sec id="s5-2">
<title>Potential role of SAB in the regulation of ferroptosis and pyroptosis</title>
<p>Ferroptosis: Ferroptosis is one of the mechanisms of stress-driven regulated cell death (RCD) of cancer cells and non-cancer cells, leading to severe lipid peroxidation as a consequence of Fenton reaction (iron and H<sub>2</sub>O<sub>2</sub> reaction generating hydroxyl or hydroperoxyl radicals) when cellular GSH synthesis and GSH is impaired (<xref ref-type="bibr" rid="B24">Galluzzi et al., 2018</xref>). Cells committed to ferroptosis exhibit necrotic morphology and mitochondrial alterations encompassing shrinkage, reduced cristae, and ruptured OMM. The ferroptosis mechanism is independent of caspases and necrosome formation, and cannot be prevented by cyclophilin D inhibitor, suggesting the distinct RCD mechanism from apoptosis, necroptosis, and necrosis. Ferroptosis is enhanced by inducers such as erastin, RSL3, and FIN56 and is prevented by iron chelators, ferrostatins, and lipid peroxidation inhibitors such as liproxstatins. Intracellular (cytoplasmic and mitochondrial) reduced glutathione (GSH) is critically important in preventing ferroptosis because GSH is a co-factor of glutathione peroxides (GPx isoforms such as GPx1 and 4) for the removal of radicals generated from H<sub>2</sub>O<sub>2</sub> and lipid peroxides. Thus, depletion or inhibition of GPx commits cells to ferroptosis inducer-induced cell death. Induction of ferroptosis enhances anticancer drug susceptibility and thus becomes an avenue for anticancer treatment. The mechanism of ferroptosis in biology and pathological processes and the anticancer therapeutic application of ferroptosis inducers have been reviewed thoroughly (<xref ref-type="bibr" rid="B98">Xie et al., 2016</xref>; <xref ref-type="bibr" rid="B96">Wu et al., 2021</xref>; <xref ref-type="bibr" rid="B99">Yan et al., 2021</xref>).</p>
<p>Lipid (mainly PUFA) peroxidation is a key step in committing to ferroptosis. The subcellular location of the initial event of lipid peroxidation may be from mitochondria, ER, or plasma membrane, and further experiments are required to clarify signal transduction pathways, leading to ROS production and lipid peroxidation. There are multiple sources of ROS in the cell including nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX), xanthine oxidase (XO), uncoupling of nitric oxide synthase (NOS), cytochrome P450, and inhibition of mitochondrial electron transport chain (ETC), and more than one source of ROS could be responsible for lipid peroxidation in ferroptosis. For instance, the RAS-mutant tumor cell, Calu-1, which expresses high NOX1, is protected from erastin-induced ferroptosis by NOX inhibitors, but human fibrosarcoma-derived epithelial cells, HT-1080 cells, are only partially protected by NOX inhibitors. In this context, the early role of mitochondrial ROS production needs further clarification. Mitochondrial O<sub>2</sub>
<sup>&#x2212;</sup> production and NOX activation cross-talk have been shown in several models (<xref ref-type="bibr" rid="B17">Dikalov, 2011</xref>); serum withdrawal of HEK293T cells activates mitochondrial O<sub>2</sub>
<sup>&#x2212;</sup> production within a few minutes and triggers NOX1 activation 4&#x2013;8&#xa0;h later (<xref ref-type="bibr" rid="B45">Lee et al., 2006</xref>). Angiotensin II-induced NOX2 activation and O<sub>2</sub>
<sup>&#x2212;</sup> production in endothelial cells <italic>via</italic> membrane-bound c-Src are reversed by mitochondrial SOD2 overexpression or mitochondrial-targeted antioxidant (Mito-TEMPO) treatment but enhanced by depletion of SOD2 (<xref ref-type="bibr" rid="B19">Dikalova et al., 2010</xref>). Based on the published evidence, a concrete approach is required to address the notion that the activation of NADPH oxidases increases the production of mitochondrial ROS and <italic>vice versa</italic> in ferroptosis of cell culture and disease models such as ischemia-reperfusion injury and HCC.</p>
<p>Notably, the expression of NOX genes (1&#x2013;5) in nontumor cells is cell/tissue-specific. In the liver, hepatocytes, hepatic stellate cells, and endothelial cells express NOX1, 2, and 4, respectively. Kupffer cells express NOX2, whereas inflammatory cells such as monocytes/macrophages express NOX1 and 2. It is important that NOX enzymes have different subcellular localization but also generate distinct ROS; NOX1 and 2 generate O<sub>2</sub>
<sup>&#x2212;</sup>, NOX4 produces basal H<sub>2</sub>O<sub>2</sub>, and NOX5 produces H<sub>2</sub>O<sub>2</sub> in a Ca<sup>2&#x2b;</sup>-dependent mechanism (<xref ref-type="bibr" rid="B18">Dikalov et al., 2008</xref>; <xref ref-type="bibr" rid="B28">Guzik et al., 2008</xref>; <xref ref-type="bibr" rid="B78">Takac et al., 2011</xref>). However, mitochondrial localization of NOX is unlikely and thoroughly discussed in another review (<xref ref-type="bibr" rid="B17">Dikalov, 2011</xref>). A recent study implied that mitochondria contribute to doxorubicin (DOX)-induced ferroptosis and cardiotoxicity (<xref ref-type="bibr" rid="B77">Tadokoro et al., 2020</xref>). DOX compared to erastin and RSL3 is a unique ferroptosis inducer, causing lipid peroxidation in mitochondria but not in other organelles because of the formation of the DOX-Fe<sup>2&#x2b;</sup> complex in mitochondria. DOX is known to activate apoptotic caspase activation in a quicker time (peak at 10&#xa0;h). GPx4 was gradually downregulated, and lipid peroxidation increased until 30&#xa0;h. Caspase inhibitor and Fer-1 partially prevent DOX-induced cell death, whereas a combination (<xref ref-type="bibr" rid="B77">Tadokoro et al., 2020</xref>) or Mito-TEMPO (<xref ref-type="bibr" rid="B22">Fang et al., 2019</xref>) fully prevents cell death. Another mitochondrial-targeted antioxidant, nitroxide XJB-5-131, also inhibits erastin or RSL3-induced ferroptosis (<xref ref-type="bibr" rid="B43">Krainz et al., 2016</xref>). Overall, these and other results implied that the regulation of mitochondrial ROS production contributes to the activation of the ferroptosis mechanism (<xref ref-type="bibr" rid="B27">Guo et al., 2022</xref>; <xref ref-type="bibr" rid="B62">Oh et al., 2022</xref>; <xref ref-type="bibr" rid="B51">Liu et al., 2023</xref>). Therefore, further investigation into ferroptosis is needed to delineate the specific function and mechanism of the JNK-SAB-ROS activation loop. The contribution of the JNK-SAB-ROS activation loop in ferroptosis has been largely ignored. The results for the role of mitochondrial-derived ROS and structural/functional changes of mitochondria certainly support this.</p>
<p>Pyroptosis: Pyroptosis is a pro-inflammatory regulated cell death with necrotic morphology characterized at the late stage by the binding of cleaved gasdermin family proteins to the plasma membrane, followed by oligomerization to form membrane pores and release of inflammatory cytokines including interleukin (IL)-1&#x3b2; and IL-18 (<xref ref-type="bibr" rid="B24">Galluzzi et al., 2018</xref>). Long before, pyroptosis was referred to as caspase-1-mediated monocyte/macrophage death in immunity against intracellular pathogens and lipopolysaccharide (LPS) (<xref ref-type="bibr" rid="B38">Jorgensen and Miao, 2015</xref>). Pyroptosis has now been described in other mammalian cells including hepatocytes, endothelial cells, neurons, nephrons, and epithelial cells (<xref ref-type="bibr" rid="B33">Huang et al., 2020</xref>; <xref ref-type="bibr" rid="B25">Gaul et al., 2021</xref>; <xref ref-type="bibr" rid="B74">Shen et al., 2021</xref>; <xref ref-type="bibr" rid="B52">Luo et al., 2022</xref>). Depending on the tissue-specific expression of mammalian gasdermin genes (A-E and DFNB59), pyroptosis is involved in diseases including liver fibrosis, inflammatory bowel disease, asthma, multiple sclerosis, nephrotoxicity, lupus nephritis, cancer, and hearing loss (<xref ref-type="bibr" rid="B25">Gaul et al., 2021</xref>; <xref ref-type="bibr" rid="B50">Liu et al., 2021</xref>; <xref ref-type="bibr" rid="B74">Shen et al., 2021</xref>; <xref ref-type="bibr" rid="B100">Yu et al., 2021</xref>; <xref ref-type="bibr" rid="B52">Luo et al., 2022</xref>). Upon cleavage of gasdermins (A, B, C, or D), the N terminus of gasdermin (GSDM-NT) binds to acidic phospholipids on the inner side of the plasma membrane and oligomerizes to form pores in the plasma membrane, and downstream protein Ninjurin-1 (NINJ1) mediated the rupture of the membrane, facilitating pyroptosis (<xref ref-type="bibr" rid="B21">Evavold et al., 2018</xref>; <xref ref-type="bibr" rid="B40">Kayagaki et al., 2021</xref>; <xref ref-type="bibr" rid="B50">Liu et al., 2021</xref>; <xref ref-type="bibr" rid="B97">Xia et al., 2021</xref>). The critical step in gasdermin cleavage is caspase-1 activation in the canonical pathway and caspase-11 (4/5 in humans) activation in the non-canonical pathway (<xref ref-type="bibr" rid="B85">Willingham et al., 2007</xref>; <xref ref-type="bibr" rid="B41">Kayagaki et al., 2011</xref>). Recently, additional caspases (3 and 8) have been identified in specific conditions exposed to chemotherapeutic agents (<xref ref-type="bibr" rid="B83">Wang Y. et al., 2017</xref>; <xref ref-type="bibr" rid="B68">Rogers et al., 2017</xref>; <xref ref-type="bibr" rid="B60">Newton et al., 2019</xref>) and granzymes (A and B) in antitumor response (<xref ref-type="bibr" rid="B107">Zhang et al., 2020</xref>; <xref ref-type="bibr" rid="B108">Zhou et al., 2020</xref>). Thus, the involvement of caspases in apoptotic or pyroptotic cell death suggests the possible existence of a critical turning point to commit to one of the modes of cell death-apoptosis or pyroptosis.</p>
<p>Intriguingly, recent findings support the critical role of mitochondria in the regulation of pyroptosis (<xref ref-type="bibr" rid="B33">Huang et al., 2020</xref>; <xref ref-type="bibr" rid="B20">Evavold et al., 2021</xref>; <xref ref-type="bibr" rid="B55">Miao et al., 2023</xref>). Mitochondria-deficient ethidium bromide-treated macrophages are highly resistant to both canonical and non-canonical pyroptosis, suggesting the specific contribution of mitochondria to pyroptosis (<xref ref-type="bibr" rid="B55">Miao et al., 2023</xref>). In fact, the cleaved N-terminus of gasdermin D (GASDMD-NT) selectively binds to mitochondrial-specific membrane phospholipid, cardiolipin, which is mainly localized at the matrix side of IMM but is present in a small amount (3%&#x2013;5%) in the OMM. GASDMD-NT affinity to cardiolipin is much higher than plasma membrane phospholipid, and mitochondria are targeted earlier than the plasma membrane. The direct mitochondrial targeting of GASDMD-NT, attenuation of mitochondrial respiration, increased ROS production, and membrane depolarization occur earlier than plasma membrane pore formation and are required to commit to the pyroptosis mode of cell death (<xref ref-type="bibr" rid="B55">Miao et al., 2023</xref>). Notably, mitochondrial antioxidant, Mito-TEMPO, prevents pyroptosis inducer-activated cell death but mitochondrial toxin, rotenone (at a low-lethal dose), which induces ROS alone is not sufficient to activate pyroptosis, suggesting an additional factor facilitating the exposure of cardiolipin to GASDMD-NT on mitochondria. Cardiolipin synthase 1 (CRLS1) in the matrix synthesizes cardiolipin which can be flipped from the matrix side of IMM to the outer side of IMM by phospholipid scramblase 3 (PLSCR3) and from there distributed to both sides of the OMM. Deletion of PLSCR3 completely prevents cardiolipin distribution to OMM and thus prevents pyroptosis inducer-activated cell death, demonstrating the absolute requirement of cardiolipin flipping to commit to pyroptosis. Of note, depolarization of IMM potential which triggers cardiolipin flipping is a plausible determinant to facilitate oligomerization of GASDMD-NT pores on mitochondria, leading to enhanced plasma membrane pore formation and cell rupture (<xref ref-type="bibr" rid="B55">Miao et al., 2023</xref>). The key question is how the mitochondrial depolarization occurs in pyroptosis. Mitochondrial membrane potential (MMP) is primarily maintained by mitochondrial respiration, which depends on NADH and ADP levels in the matrix. Recently, stress kinase (JNK) translocation and interaction with OMM protein SAB (SH3BP5) mediate the inhibition of mitochondrial respiration (<xref ref-type="bibr" rid="B94">Win et al., 2016</xref>), suggesting the possible involvement of SAB and P-JNK interaction in pyroptosis. In fact, ROS and the activated form of JNK (P-JNK) are upstream of caspase-3 activation in doxorubicin-induced GASDME cleavage and pyroptosis in breast cancer cells (<xref ref-type="bibr" rid="B106">Zhang et al., 2021</xref>). In addition, JNK is activated by inflammasome and high glucose in diabetic nephropathy (<xref ref-type="bibr" rid="B66">Qiao et al., 2018</xref>). Moreover, caspase 11 expression is upregulated by activated JNK-mediated transcription in macrophages of mouse models of enteropathogenic <italic>Citrobacter rodentium</italic> infection (<xref ref-type="bibr" rid="B53">Lupfer et al., 2014</xref>). Although the role of mitochondria translocated JNK in the regulation of pyroptosis was not yet assessed, JNK activation plays a role in enhanced inflammasome activation, increased caspase-11 expression and activation, caspase 3 activation, gasdermin cleavage, and pyroptosis.</p>
<p>Externalized cardiolipin signals several pathways that target mitochondria, such as mitophagy <italic>via</italic> autophagosome formation, apoptosis <italic>via</italic> Bid cleavage by activated caspase-8 promoting oligomerized BAX/BAK pore on OMM, and releasing cytochrome c. Therefore, the mitochondrial signals of the cell fate are overlapping, but the faster mitochondrial targeting of GASDMD-NT and subsequent targeting of GASDMD-NT to the plasma membrane commit the cells to pyroptosis mode of death, causing inflammatory responses. Recently, genome-wide screening identified the Ragulator&#x2013;Rag complex through positive regulation of mTOR1 signaling as necessary for GSDMD pore formation. However, Rag and mTOR are not directly involved in GASDMD cleavage and pore formation, but mitochondrial ROS production is associated to facilitate GASDMD-NT pore formation on the plasma membrane (<xref ref-type="bibr" rid="B20">Evavold et al., 2021</xref>). This finding proposes that other activators of the mTOR pathway such as growth factors, glucose, cytokine receptors, and Toll-like receptor (TLR) ligands (<xref ref-type="bibr" rid="B47">Liu and Sabatini, 2020</xref>) could promote GASDMD oligomerization when the condition is associated with mitochondrial ROS production. In addition, GASDMD can be post-translationally modified by mitochondrial citric acid cycle intermediates (<xref ref-type="bibr" rid="B34">Humphries et al., 2020</xref>). Therefore, pyroptosis is not only a mode of cell death due to canonical and non-canonical inflammasomes but also could occur in metabolic stress in cells. Updates on pyroptosis mechanism and gasdermin-associated diseases have been thoroughly reviewed recently (<xref ref-type="bibr" rid="B75">Shi et al., 2017</xref>; <xref ref-type="bibr" rid="B50">Liu et al., 2021</xref>; <xref ref-type="bibr" rid="B100">Yu et al., 2021</xref>).</p>
</sec>
<sec id="s5-3">
<title>SAB as a biomarker and therapeutic target</title>
<p>Chambers et al. reported investigations that led to the recognition of SAB as a biomarker and therapeutic target. As we discussed, the level of SAB expression in mitochondria determines the sustainability of P-JNK and cell death or disease severity. In the murine model, acetaminophen-induced liver injury is reduced in adult female mice because of lower basal expression of SAB in females than in males (<xref ref-type="bibr" rid="B87">Win et al., 2019</xref>). Progressive increased SAB expression is noted in the diet-induced progression of metabolic dysfunction-associated steatohepatitis (MASH, new nomenclature of NASH), and dialing up the level of P-JNK in the liver directly correlates with the level of SAB (<xref ref-type="bibr" rid="B87">Win et al., 2019</xref>; <xref ref-type="bibr" rid="B88">Win et al., 2021</xref>). In addition, the level of SAB expression predicts the chemotherapeutic drug sensitivity of various ovarian cancer cells (<xref ref-type="bibr" rid="B11">Chambers et al., 2015</xref>; <xref ref-type="bibr" rid="B65">Paudel et al., 2018</xref>). These intriguing results deserve further investigation of the clinical relevance of the SAB protein level and the mechanisms that regulate SAB expression.</p>
<p>SAB is expressed ubiquitously in various cells and tissues with high expression in the adrenal gland, fat, brain, heart, bone marrow, lymph node, and ovary. Chamber et al. first developed the KIM1 peptide (peptide sequence mimic to KIM1 amino acid sequence) designed to block SAB and P-JNK interaction in an <italic>in vitro</italic> binding assay system before the topology of SAB in mitochondria was characterized (<xref ref-type="bibr" rid="B6">Chambers et al., 2011a</xref>; <xref ref-type="bibr" rid="B8">Chambers and LoGrasso, 2011</xref>; <xref ref-type="bibr" rid="B94">Win et al., 2016</xref>). Membrane permeable form of KIM1 peptide in <italic>in vitro</italic> and <italic>in vivo</italic> models blocked JNK-mediated mitochondrial impairment, supporting the conclusion that the KIM1 peptide competitively prevents P-JNK binding to KIM2 because the KIM1 sequence has a higher affinity than KIM2 in binding assay (<xref ref-type="bibr" rid="B6">Chambers et al., 2011a</xref>; <xref ref-type="bibr" rid="B8">Chambers and LoGrasso, 2011</xref>). Furthermore, the KIM1 peptide prevents numerous models of JNK-mediated disease including 6-hydroxydopamine-induced toxicity in the brain, Parkinson&#x2019;s disease, ischemia/reperfusion injury of the heart, and cardiotoxicity model. All these results suggest that the JNK-SAB-ROS activation loop is a feasible target for therapeutic development. In addition, targeting SAB expression dampens sustained JNK activation which offers therapeutic application (<xref ref-type="bibr" rid="B88">Win et al., 2021</xref>). KIM1 peptide can selectively block P-JNK binding to SAB without interfering with the JNK kinase activity (<xref ref-type="bibr" rid="B6">Chambers et al., 2011a</xref>; <xref ref-type="bibr" rid="B89">Win et al., 2014</xref>; <xref ref-type="bibr" rid="B93">Win et al., 2015</xref>) and has a specificity compared to the JIP-peptide which has a broader inhibitory action (<xref ref-type="bibr" rid="B2">Barr et al., 2002</xref>). However, the discovery of small molecules specifically targeting JNK and SAB interaction seems challenging. Alternatively, modulation of SAB gene expression may be possible using antisense oligonucleotides (<xref ref-type="bibr" rid="B88">Win et al., 2021</xref>). Importantly, there is no phenotype difference between wild type <italic>versus</italic> absence of hepatic SAB (knockout or knockdown of SAB in the liver). Modulating SAB expression may be a promising therapeutic approach in chronic diseases and cancer treatment.</p>
</sec>
</sec>
<sec sec-type="conclusion" id="s6">
<title>Conclusion</title>
<p>The JNK-SAB-ROS activation loop was uncovered recently, but the importance of the loop in the regulation of various modes of cell death has not been incorporated. This review has proposed the possible involvement of JNK and SAB interaction in ferroptosis and pyroptosis. In fact, the JNK-SAB-ROS activation loop can be modulated by crosstalk regulations, such as increased expression of DUSP <italic>via</italic> the p38a/MK2 pathway (<xref ref-type="bibr" rid="B44">Lalaoui et al., 2016</xref>), delayed antioxidant GSH recovery by activated JNK targeting, and degradation of GCLC (<xref ref-type="bibr" rid="B92">Win et al., 2023</xref>), and extensive protein nitration and lipid peroxidation by increased uptake of Fe<sup>2&#x2b;</sup> released from lysosomes (<xref ref-type="bibr" rid="B32">Hu and Lemasters, 2020</xref>; <xref ref-type="bibr" rid="B1">Adelusi et al., 2022</xref>). The liver is a unique organ with the capability to synthesize GSH, which is a major antioxidant system preventing cell death (<xref ref-type="bibr" rid="B63">Ookhtens and Kaplowitz, 1998</xref>; <xref ref-type="bibr" rid="B101">Yuan and Kaplowitz, 2009</xref>). Therefore, upregulation of NRF2 (<italic>NFE2L2</italic>) in oxidative stress and NF-&#x3ba;B (<italic>NFKB1</italic>) mediated the expression of mitochondrial antioxidants; superoxide dismutase 2 (SOD2) could interfere with the cell death pathways in hepatocytes compared to other organs and cells (<xref ref-type="bibr" rid="B58">Morgan and Liu, 2011</xref>; <xref ref-type="bibr" rid="B29">Han et al., 2013</xref>). However, the crucial role of JNK&#x2013;SAB interaction was reported in cardiotoxicity, ischemia/reperfusion cardiac injury, neurotoxicity of the brain, Parkinson&#x2019;s disease model, and neuronal activity of the brain (<xref ref-type="bibr" rid="B9">Chambers et al., 2011b</xref>; <xref ref-type="bibr" rid="B10">Chambers et al., 2013a</xref>; <xref ref-type="bibr" rid="B7">Chambers et al., 2013b</xref>; <xref ref-type="bibr" rid="B12">Chambers et al., 2017</xref>; <xref ref-type="bibr" rid="B76">Sodero et al., 2017</xref>). Therefore, interfering with the JNK-SAB-ROS pathway directly or indirectly modulates the mode of cell death.</p>
</sec>
</body>
<back>
<sec id="s7">
<title>Author contributions</title>
<p>SW: conceptualization, writing&#x2013;original draft, and writing&#x2013;review and editing. TT: conceptualization, writing&#x2013;original draft, and writing&#x2013;review and editing. NK: conceptualization writing&#x2013;review and editing.</p>
</sec>
<sec sec-type="funding-information" id="s8">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research, authorship, and/or publication of this article. The discussion in this review article is developed on the research data supported by the National Institutes of Health R01DK067215 (NK) and R01DK126866 (NK); the Veronica Gerrie Budnick Chair in Liver Disease (NK); the Donald E. and Delia Baxter Foundation Faculty Fellows award (SW), a pilot project award to SW by USC Research Center for Liver Diseases; and the USC Research Center for Liver Disease&#x2019;s Cell Separation and Culture, Cell and Tissue Imaging, Histology, and Metabolic/Analytical/Instrumentation Cores P30DK048522 (NK).</p>
</sec>
<sec sec-type="COI-statement" id="s9">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s10">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors, and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adelusi</surname>
<given-names>O. B.</given-names>
</name>
<name>
<surname>Ramachandran</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lemasters</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>Jaeschke</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>The role of Iron in lipid peroxidation and protein nitration during acetaminophen-induced liver injury in mice</article-title>. <source>Toxicol. Appl. Pharmacol.</source> <volume>445</volume>, <fpage>116043</fpage>. <pub-id pub-id-type="doi">10.1016/j.taap.2022.116043</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barr</surname>
<given-names>R. K.</given-names>
</name>
<name>
<surname>Kendrick</surname>
<given-names>T. S.</given-names>
</name>
<name>
<surname>Bogoyevitch</surname>
<given-names>M. A.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Identification of the critical features of a small peptide inhibitor of JNK activity</article-title>. <source>J. Biol. Chem.</source> <volume>277</volume> (<issue>13</issue>), <fpage>10987</fpage>&#x2013;<lpage>10997</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M107565200</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brand</surname>
<given-names>M. D.</given-names>
</name>
<name>
<surname>Affourtit</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Esteves</surname>
<given-names>T. C.</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Lambert</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Miwa</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2004</year>). <article-title>Mitochondrial superoxide: production, biological effects, and activation of uncoupling proteins</article-title>. <source>Free Radic. Biol. Med.</source> <volume>37</volume> (<issue>6</issue>), <fpage>755</fpage>&#x2013;<lpage>767</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2004.05.034</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brown</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Strudwick</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Suwara</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sutcliffe</surname>
<given-names>L. K.</given-names>
</name>
<name>
<surname>Mihai</surname>
<given-names>A. D.</given-names>
</name>
<name>
<surname>Ali</surname>
<given-names>A. A.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>An initial phase of JNK activation inhibits cell death early in the endoplasmic reticulum stress response</article-title>. <source>J. Cell Sci.</source> <volume>129</volume> (<issue>12</issue>), <fpage>2317</fpage>&#x2013;<lpage>2328</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.179127</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cebula</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>E. E.</given-names>
</name>
<name>
<surname>Arn&#xe9;r</surname>
<given-names>E. S.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>TrxR1 as a potent regulator of the Nrf2-Keap1 response system</article-title>. <source>Antioxid. Redox Signal</source> <volume>23</volume> (<issue>10</issue>), <fpage>823</fpage>&#x2013;<lpage>853</lpage>. <pub-id pub-id-type="doi">10.1089/ars.2015.6378</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chambers</surname>
<given-names>J. W.</given-names>
</name>
<name>
<surname>Cherry</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Laughlin</surname>
<given-names>J. D.</given-names>
</name>
<name>
<surname>Figuera-Losada</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lograsso</surname>
<given-names>P. V.</given-names>
</name>
</person-group> (<year>2011a</year>). <article-title>Selective inhibition of mitochondrial JNK signaling achieved using peptide mimicry of the Sab kinase interacting motif-1 (KIM1)</article-title>. <source>ACS Chem. Biol.</source> <volume>6</volume> (<issue>8</issue>), <fpage>808</fpage>&#x2013;<lpage>818</lpage>. <pub-id pub-id-type="doi">10.1021/cb200062a</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chambers</surname>
<given-names>J. W.</given-names>
</name>
<name>
<surname>Howard</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>LoGrasso</surname>
<given-names>P. V.</given-names>
</name>
</person-group> (<year>2013b</year>). <article-title>Blocking c-Jun N-terminal kinase (JNK) translocation to the mitochondria prevents 6-hydroxydopamine-induced toxicity <italic>in vitro</italic> and <italic>in vivo</italic>
</article-title>. <source>J. Biol. Chem.</source> <volume>288</volume> (<issue>2</issue>), <fpage>1079</fpage>&#x2013;<lpage>1087</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M112.421354</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chambers</surname>
<given-names>J. W.</given-names>
</name>
<name>
<surname>LoGrasso</surname>
<given-names>P. V.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Mitochondrial c-Jun N-terminal kinase (JNK) signaling initiates physiological changes resulting in amplification of reactive oxygen species generation</article-title>. <source>J. Biol. Chem.</source> <volume>286</volume> (<issue>18</issue>), <fpage>16052</fpage>&#x2013;<lpage>16062</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M111.223602</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chambers</surname>
<given-names>J. W.</given-names>
</name>
<name>
<surname>Pachori</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Howard</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ganno</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Kamenecka</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2011b</year>). <article-title>Small molecule c-jun-N-terminal kinase (JNK) inhibitors protect dopaminergic neurons in a model of Parkinson&#x27;s disease</article-title>. <source>ACS Chem. Neurosci.</source> <volume>2</volume> (<issue>4</issue>), <fpage>198</fpage>&#x2013;<lpage>206</lpage>. <pub-id pub-id-type="doi">10.1021/cn100109k</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chambers</surname>
<given-names>J. W.</given-names>
</name>
<name>
<surname>Pachori</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Howard</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Iqbal</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>LoGrasso</surname>
<given-names>P. V.</given-names>
</name>
</person-group> (<year>2013a</year>). <article-title>Inhibition of JNK mitochondrial localization and signaling is protective against ischemia/reperfusion injury in rats</article-title>. <source>J. Biol. Chem.</source> <volume>288</volume> (<issue>6</issue>), <fpage>4000</fpage>&#x2013;<lpage>4011</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M112.406777</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chambers</surname>
<given-names>T. P.</given-names>
</name>
<name>
<surname>Portalatin</surname>
<given-names>G. M.</given-names>
</name>
<name>
<surname>Paudel</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Robbins</surname>
<given-names>C. J.</given-names>
</name>
<name>
<surname>Chambers</surname>
<given-names>J. W.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Sub-chronic administration of LY294002 sensitizes cervical cancer cells to chemotherapy by enhancing mitochondrial JNK signaling</article-title>. <source>Biochem. Biophys. Res. Commun.</source> <volume>463</volume> (<issue>4</issue>), <fpage>538</fpage>&#x2013;<lpage>544</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2015.05.075</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chambers</surname>
<given-names>T. P.</given-names>
</name>
<name>
<surname>Santiesteban</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Gomez</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Chambers</surname>
<given-names>J. W.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Sab mediates mitochondrial dysfunction involved in imatinib mesylate-induced cardiotoxicity</article-title>. <source>Toxicology</source> <volume>382</volume>, <fpage>24</fpage>&#x2013;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1016/j.tox.2017.03.006</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Kamata</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Solinas</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname>Maeda</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Venuprasad</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2006</year>). <article-title>The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover</article-title>. <source>Cell</source> <volume>124</volume> (<issue>3</issue>), <fpage>601</fpage>&#x2013;<lpage>613</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2006.01.021</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cockrell</surname>
<given-names>L. M.</given-names>
</name>
<name>
<surname>Puckett</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Goldman</surname>
<given-names>E. H.</given-names>
</name>
<name>
<surname>Khuri</surname>
<given-names>F. R.</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Dual engagement of 14-3-3 proteins controls signal relay from ASK2 to the ASK1 signalosome</article-title>. <source>Oncogene</source> <volume>29</volume> (<issue>6</issue>), <fpage>822</fpage>&#x2013;<lpage>830</lpage>. <pub-id pub-id-type="doi">10.1038/onc.2009.382</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Court</surname>
<given-names>N. W.</given-names>
</name>
<name>
<surname>Kuo</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Quigley</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Bogoyevitch</surname>
<given-names>M. A.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Phosphorylation of the mitochondrial protein Sab by stress-activated protein kinase 3</article-title>. <source>Biochem. Biophys. Res. Commun.</source> <volume>319</volume> (<issue>1</issue>), <fpage>130</fpage>&#x2013;<lpage>137</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2004.04.148</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dhanasekaran</surname>
<given-names>D. N.</given-names>
</name>
<name>
<surname>Reddy</surname>
<given-names>E. P.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>JNK signaling in apoptosis</article-title>. <source>Oncogene</source> <volume>27</volume> (<issue>48</issue>), <fpage>6245</fpage>&#x2013;<lpage>6251</lpage>. <comment>10-20 2008</comment>. <pub-id pub-id-type="doi">10.1038/onc.2008.301</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dikalov</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Cross talk between mitochondria and NADPH oxidases</article-title>. <source>Free Radic. Biol. Med.</source> <volume>51</volume> (<issue>7</issue>), <fpage>1289</fpage>&#x2013;<lpage>1301</lpage>. <comment>10-01 2011</comment>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2011.06.033</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dikalov</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Dikalova</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bikineyeva</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Harrison</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Griendling</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production</article-title>. <source>Free Radic. Biol. Med.</source> <volume>45</volume> (<issue>9</issue>), <fpage>1340</fpage>&#x2013;<lpage>1351</lpage>. <comment>11-01 2008</comment>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2008.08.013</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dikalova</surname>
<given-names>A. E.</given-names>
</name>
<name>
<surname>Bikineyeva</surname>
<given-names>A. T.</given-names>
</name>
<name>
<surname>Budzyn</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Nazarewicz</surname>
<given-names>R. R.</given-names>
</name>
<name>
<surname>McCann</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>W.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>Therapeutic targeting of mitochondrial superoxide in hypertension</article-title>. <source>Circulation Res.</source> <volume>107</volume> (<issue>1</issue>), <fpage>106</fpage>&#x2013;<lpage>116</lpage>. <comment>07-09 2010</comment>. <pub-id pub-id-type="doi">10.1161/circresaha.109.214601</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Evavold</surname>
<given-names>C. L.</given-names>
</name>
<name>
<surname>Hafner-Bratkovi&#x10d;</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Devant</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>D&#x27;Andrea</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Ngwa</surname>
<given-names>E. M.</given-names>
</name>
<name>
<surname>Bor&#x161;i&#x107;</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Control of gasdermin D oligomerization and pyroptosis by the Ragulator-Rag-mTORC1 pathway</article-title>. <source>Cell</source> <volume>184</volume> (<issue>17</issue>), <fpage>4495</fpage>&#x2013;<lpage>4511.e19</lpage>. <comment>08-01 2021</comment>. <pub-id pub-id-type="doi">10.1016/j.cell.2021.06.028</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Evavold</surname>
<given-names>C. L.</given-names>
</name>
<name>
<surname>Ruan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kagan</surname>
<given-names>J. C.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>The pore-forming protein gasdermin D regulates interleukin-1 secretion from living macrophages</article-title>. <source>Immunity</source> <volume>48</volume> (<issue>1</issue>), <fpage>35</fpage>&#x2013;<lpage>44</lpage>. <comment>01-01 2018</comment>. <pub-id pub-id-type="doi">10.1016/j.immuni.2017.11.013</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Ferroptosis as a target for protection against cardiomyopathy</article-title>. <source>Proc. Natl. Acad. Sci.</source> <volume>116</volume> (<issue>7</issue>), <fpage>2672</fpage>&#x2013;<lpage>2680</lpage>. <comment>02-12 2019</comment>. <pub-id pub-id-type="doi">10.1073/pnas.1821022116</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Foster</surname>
<given-names>D. B.</given-names>
</name>
<name>
<surname>Van Eyk</surname>
<given-names>J. E.</given-names>
</name>
<name>
<surname>Marb&#xe1;n</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>O&#x27;Rourke</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Redox signaling and protein phosphorylation in mitochondria: progress and prospects</article-title>. <source>J. Bioenerg. Biomembr.</source> <volume>41</volume> (<issue>2</issue>), <fpage>159</fpage>&#x2013;<lpage>168</lpage>. <pub-id pub-id-type="doi">10.1007/s10863-009-9217-7</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Galluzzi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Vitale</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Aaronson</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Abrams</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Adam</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Agostinis</surname>
<given-names>P.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death</article-title>. <source>Cell Death Differ.</source> <volume>25</volume> (<issue>3</issue>), <fpage>486</fpage>&#x2013;<lpage>541</lpage>. <comment>2018-03-01 2018</comment>. <pub-id pub-id-type="doi">10.1038/s41418-017-0012-4</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gaul</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Leszczynska</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Alegre</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Kaufmann</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>C. D.</given-names>
</name>
<name>
<surname>Adams</surname>
<given-names>L. A.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis</article-title>. <source>J. Hepatology</source> <volume>74</volume> (<issue>1</issue>), <fpage>156</fpage>&#x2013;<lpage>167</lpage>. <comment>01-01 2021</comment>. <pub-id pub-id-type="doi">10.1016/j.jhep.2020.07.041</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goto-Ito</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Morooka</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Yamagata</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Fukai</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Structural basis of guanine nucleotide exchange for Rab11 by SH3BP5</article-title>. <source>Life Sci. Alliance</source> <volume>2</volume> (<issue>2</issue>), <fpage>e201900297</fpage>. <comment>04-01 2019</comment>. <pub-id pub-id-type="doi">10.26508/lsa.201900297</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Mitochondria as multifaceted regulators of ferroptosis</article-title>. <source>Life Metab.</source> <volume>1</volume> (<issue>2</issue>), <fpage>134</fpage>&#x2013;<lpage>148</lpage>. <comment>12-25 2022</comment>. <pub-id pub-id-type="doi">10.1093/lifemeta/loac035</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guzik</surname>
<given-names>T. J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Gongora</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Guzik</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Lob</surname>
<given-names>H. E.</given-names>
</name>
<name>
<surname>Mangalat</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2008</year>). <article-title>Calcium-dependent NOX5 nicotinamide adenine dinucleotide phosphate oxidase contributes to vascular oxidative stress in human coronary artery disease</article-title>. <source>J. Am. Coll. Cardiol.</source> <volume>52</volume> (<issue>22</issue>), <fpage>1803</fpage>&#x2013;<lpage>1809</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2008.07.063</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Dara</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Win</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Than</surname>
<given-names>T. A.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Abbasi</surname>
<given-names>S. Q.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Regulation of drug-induced liver injury by signal transduction pathways: critical role of mitochondria</article-title>. <source>Trends Pharmacol. Sci.</source> <volume>34</volume> (<issue>4</issue>), <fpage>243</fpage>&#x2013;<lpage>253</lpage>. <pub-id pub-id-type="doi">10.1016/j.tips.2013.01.009</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heslop</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>Rovini</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hunt</surname>
<given-names>E. G.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>Christie</surname>
<given-names>C. F.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>JNK activation and translocation to mitochondria mediates mitochondrial dysfunction and cell death induced by VDAC opening and sorafenib in hepatocarcinoma cells</article-title>. <source>Biochem. Pharmacol.</source> <volume>171</volume>, <fpage>113728</fpage>. <comment>01-01 2020</comment>. <pub-id pub-id-type="doi">10.1016/j.bcp.2019.113728</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holzer</surname>
<given-names>R. G.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>E. J.</given-names>
</name>
<name>
<surname>Tran</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Solinas</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Saturated fatty acids induce c-Src clustering within membrane subdomains, leading to JNK activation</article-title>. <source>Cell</source> <volume>147</volume> (<issue>1</issue>), <fpage>173</fpage>&#x2013;<lpage>184</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2011.08.034</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lemasters</surname>
<given-names>J. J.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Suppression of iron mobilization from lysosomes to mitochondria attenuates liver injury after acetaminophen overdose <italic>in vivo</italic> in mice: protection by minocycline</article-title>. <source>Toxicol. Appl. Pharmacol.</source> <volume>392</volume>, <fpage>114930</fpage>. <pub-id pub-id-type="doi">10.1016/j.taap.2020.114930</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>L. S.</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>mtDNA activates cGAS signaling and suppresses the YAP-mediated endothelial cell proliferation program to promote inflammatory injury</article-title>. <source>Immunity</source> <volume>52</volume> (<issue>3</issue>), <fpage>475</fpage>&#x2013;<lpage>486</lpage>. <comment>03-01 2020</comment>. <pub-id pub-id-type="doi">10.1016/j.immuni.2020.02.002</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Humphries</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Shmuel-Galia</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ketelut-Carneiro</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Nemmara</surname>
<given-names>V. V.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Succination inactivates gasdermin D and blocks pyroptosis</article-title>. <source>Science</source> <volume>369</volume> (<issue>6511</issue>), <fpage>1633</fpage>&#x2013;<lpage>1637</lpage>. <pub-id pub-id-type="doi">10.1126/science.abb9818</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huo</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Win</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Than</surname>
<given-names>T. A.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Antcin H protects against acute liver injury through disruption of the interaction of c-jun-N-terminal kinase with mitochondria</article-title>. <source>Antioxid. Redox Signal</source> <volume>26</volume> (<issue>5</issue>), <fpage>207</fpage>&#x2013;<lpage>220</lpage>. <pub-id pub-id-type="doi">10.1089/ars.2016.6833</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Inokuchi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Aoyama</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Miura</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Osterreicher</surname>
<given-names>C. H.</given-names>
</name>
<name>
<surname>Kodama</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Miyai</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>107</volume> (<issue>2</issue>), <fpage>844</fpage>&#x2013;<lpage>849</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0909781107</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jenkins</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>Margaria</surname>
<given-names>J. P.</given-names>
</name>
<name>
<surname>Stariha</surname>
<given-names>J. T. B.</given-names>
</name>
<name>
<surname>Hoffmann</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>McPhail</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Hamelin</surname>
<given-names>D. J.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Structural determinants of Rab11 activation by the guanine nucleotide exchange factor SH3BP5</article-title>. <source>Nat. Commun.</source> <volume>9</volume> (<issue>1</issue>), <fpage>3772</fpage>. <comment>09-14 2018</comment>. <pub-id pub-id-type="doi">10.1038/s41467-018-06196-z</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jorgensen</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Miao</surname>
<given-names>E. A.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Pyroptotic cell death defends against intracellular pathogens</article-title>. <source>Immunol. Rev.</source> <volume>265</volume> (<issue>1</issue>), <fpage>130</fpage>&#x2013;<lpage>142</lpage>. <comment>-05-01 2015</comment>. <pub-id pub-id-type="doi">10.1111/imr.12287</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kawarazaki</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ichijo</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Naguro</surname>
<given-names>I.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Apoptosis signal-regulating kinase 1 as a therapeutic target</article-title>. <source>Expert Opin. Ther. Targets</source> <volume>18</volume> (<issue>6</issue>), <fpage>651</fpage>&#x2013;<lpage>664</lpage>. <pub-id pub-id-type="doi">10.1517/14728222.2014.896903</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kayagaki</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kornfeld</surname>
<given-names>O. S.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>B. L.</given-names>
</name>
<name>
<surname>Stowe</surname>
<given-names>I. B.</given-names>
</name>
<name>
<surname>O&#x27;Rourke</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Q.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>NINJ1 mediates plasma membrane rupture during lytic cell death</article-title>. <source>Nature</source> <volume>591</volume> (<issue>7848</issue>), <fpage>131</fpage>&#x2013;<lpage>136</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-021-03218-7</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kayagaki</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Warming</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lamkanfi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Vande Walle</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Louie</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Non-canonical inflammasome activation targets caspase-11</article-title>. <source>Nature</source> <volume>479</volume> (<issue>7371</issue>), <fpage>117</fpage>&#x2013;<lpage>121</lpage>. <pub-id pub-id-type="doi">10.1038/nature10558</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kelkar</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Standen</surname>
<given-names>C. L.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>R. J.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Role of the JIP4 scaffold protein in the regulation of mitogen-activated protein kinase signaling pathways</article-title>. <source>Mol. Cell Biol.</source> <volume>25</volume> (<issue>7</issue>), <fpage>2733</fpage>&#x2013;<lpage>2743</lpage>. <pub-id pub-id-type="doi">10.1128/mcb.25.7.2733-2743.2005</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krainz</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Gaschler</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Sacher</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Stockwell</surname>
<given-names>B. R.</given-names>
</name>
<name>
<surname>Wipf</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>A mitochondrial-targeted nitroxide is a potent inhibitor of ferroptosis</article-title>. <source>ACS Cent. Sci.</source> <volume>2</volume> (<issue>9</issue>), <fpage>653</fpage>&#x2013;<lpage>659</lpage>. <pub-id pub-id-type="doi">10.1021/acscentsci.6b00199</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lalaoui</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>H&#xe4;nggi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Brumatti</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Chau</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>N. Y. N.</given-names>
</name>
<name>
<surname>Vasilikos</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Targeting p38 or MK2 enhances the anti-leukemic activity of smac-mimetics</article-title>. <source>Cancer Cell</source> <volume>29</volume> (<issue>2</issue>), <fpage>145</fpage>&#x2013;<lpage>158</lpage>. <pub-id pub-id-type="doi">10.1016/j.ccell.2016.01.006</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>S. B.</given-names>
</name>
<name>
<surname>Bae</surname>
<given-names>I. H.</given-names>
</name>
<name>
<surname>Bae</surname>
<given-names>Y. S.</given-names>
</name>
<name>
<surname>Um</surname>
<given-names>H.-D.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Link between mitochondria and NADPH oxidase 1 isozyme for the sustained production of reactive oxygen species and cell death</article-title>. <source>J. Biol. Chem.</source> <volume>281</volume> (<issue>47</issue>), <fpage>36228</fpage>&#x2013;<lpage>36235</lpage>. <comment>11-01 2006</comment>. <pub-id pub-id-type="doi">10.1074/jbc.m606702200</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liang</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>McGrath</surname>
<given-names>B. C.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Cavener</surname>
<given-names>D. R.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>PERK (eIF2alpha kinase) is required to activate the stress-activated MAPKs and induce the expression of immediate-early genes upon disruption of ER calcium homoeostasis</article-title>. <source>Biochem. J.</source> <volume>393</volume> (<issue>Pt 1</issue>), <fpage>201</fpage>&#x2013;<lpage>209</lpage>. <pub-id pub-id-type="doi">10.1042/bj20050374</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>G. Y.</given-names>
</name>
<name>
<surname>Sabatini</surname>
<given-names>D. M.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>mTOR at the nexus of nutrition, growth, ageing and disease</article-title>. <source>Nat. Rev. Mol. Cell Biol.</source> <volume>21</volume> (<issue>4</issue>), <fpage>183</fpage>&#x2013;<lpage>203</lpage>. <pub-id pub-id-type="doi">10.1038/s41580-019-0199-y</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Role of JNK activation in apoptosis: a double-edged sword</article-title>. <source>Cell Res.</source> <volume>15</volume> (<issue>1</issue>), <fpage>36</fpage>&#x2013;<lpage>42</lpage>. <comment>01-01 2005</comment>. <pub-id pub-id-type="doi">10.1038/sj.cr.7290262</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Rehman</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Krishnasamy</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Schnellmann</surname>
<given-names>R. G.</given-names>
</name>
<name>
<surname>Lemasters</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Improvement of liver injury and survival by JNK2 and iNOS deficiency in liver transplants from cardiac death mice</article-title>. <source>J. Hepatol.</source> <volume>63</volume> (<issue>1</issue>), <fpage>68</fpage>&#x2013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1016/j.jhep.2015.02.017</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lieberman</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Channelling inflammation: gasdermins in physiology and disease</article-title>. <source>Nat. Rev. Drug Discov.</source> <volume>20</volume> (<issue>5</issue>), <fpage>384</fpage>&#x2013;<lpage>405</lpage>. <comment>05-01 2021</comment>. <pub-id pub-id-type="doi">10.1038/s41573-021-00154-z</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Y. E.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>L.-L.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>The diversified role of mitochondria in ferroptosis in cancer</article-title>. <source>Cell Death Dis.</source> <volume>14</volume> (<issue>8</issue>), <fpage>519</fpage>. <comment>08-14 2023</comment>. <pub-id pub-id-type="doi">10.1038/s41419-023-06045-y</pub-id>
</citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Zhai</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>W.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Blocking GSDME-mediated pyroptosis in renal tubular epithelial cells alleviates disease activity in lupus mice</article-title>. <source>Cell Death Discov.</source> <volume>8</volume> (<issue>1</issue>), <fpage>113</fpage>. <comment>03-12 2022</comment>. <pub-id pub-id-type="doi">10.1038/s41420-022-00848-2</pub-id>
</citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lupfer</surname>
<given-names>C. R.</given-names>
</name>
<name>
<surname>Anand</surname>
<given-names>P. K.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Stokes</surname>
<given-names>K. L.</given-names>
</name>
<name>
<surname>Vogel</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Lamkanfi</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Reactive oxygen species regulate caspase-11 expression and activation of the non-canonical NLRP3 inflammasome during enteric pathogen infection</article-title>. <source>PLoS Pathog.</source> <volume>10</volume> (<issue>9</issue>), <fpage>e1004410</fpage>. <comment>09-25 2014</comment>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1004410</pub-id>
</citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matsushita</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yamadori</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kato</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Takemoto</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Inazawa</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Baba</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>1998</year>). <article-title>Identification and characterization of a novel SH3-domain binding protein, Sab, which preferentially associates with Bruton&#x27;s tyrosine kinase (BtK)</article-title>. <source>Biochem. Biophys. Res. Commun.</source> <volume>245</volume> (<issue>2</issue>), <fpage>337</fpage>&#x2013;<lpage>343</lpage>. <pub-id pub-id-type="doi">10.1006/bbrc.1998.8420</pub-id>
</citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miao</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>W. Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>An</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ho</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Gasdermin D permeabilization of mitochondrial inner and outer membranes accelerates and enhances pyroptosis</article-title>. <source>Immunity</source> <volume>56</volume> (<issue>11</issue>), <fpage>2523</fpage>&#x2013;<lpage>2541.e8</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2023.10.004</pub-id>
</citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miyazaki</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Neff</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Horne</surname>
<given-names>W. C.</given-names>
</name>
<name>
<surname>Baron</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Regulation of cytochrome c oxidase activity by c-Src in osteoclasts</article-title>. <source>J. Cell Biol.</source> <volume>160</volume> (<issue>5</issue>), <fpage>709</fpage>&#x2013;<lpage>718</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200209098</pub-id>
</citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morel</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Standen</surname>
<given-names>C. L.</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>D. Y.</given-names>
</name>
<name>
<surname>Gray</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ong</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Flavell</surname>
<given-names>R. A.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>Requirement of JIP1-mediated c-Jun N-terminal kinase activation for obesity-induced insulin resistance</article-title>. <source>Mol. Cell Biol.</source> <volume>30</volume> (<issue>19</issue>), <fpage>4616</fpage>&#x2013;<lpage>4625</lpage>. <pub-id pub-id-type="doi">10.1128/mcb.00585-10</pub-id>
</citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morgan</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z.-G.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Crosstalk of reactive oxygen species and NF-&#x3ba;B signaling</article-title>. <source>Cell Res.</source> <volume>21</volume> (<issue>1</issue>), <fpage>103</fpage>&#x2013;<lpage>115</lpage>. <pub-id pub-id-type="doi">10.1038/cr.2010.178</pub-id>
</citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nagai</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Noguchi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Homma</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Katagiri</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Takeda</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Matsuzawa</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>Ubiquitin-like sequence in ASK1 plays critical roles in the recognition and stabilization by USP9X and oxidative stress-induced cell death</article-title>. <source>Mol. Cell</source> <volume>36</volume> (<issue>5</issue>), <fpage>805</fpage>&#x2013;<lpage>818</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2009.10.016</pub-id>
</citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Newton</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Wickliffe</surname>
<given-names>K. E.</given-names>
</name>
<name>
<surname>Maltzman</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Dugger</surname>
<given-names>D. L.</given-names>
</name>
<name>
<surname>Reja</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Activity of caspase-8 determines plasticity between cell death pathways</article-title>. <source>Nature</source> <volume>575</volume> (<issue>7784</issue>), <fpage>679</fpage>&#x2013;<lpage>682</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-019-1752-8</pub-id>
</citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ogura</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yamaki</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Homma</surname>
<given-names>M. K.</given-names>
</name>
<name>
<surname>Homma</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Mitochondrial c-Src regulates cell survival through phosphorylation of respiratory chain components</article-title>. <source>Biochem. J.</source> <volume>447</volume> (<issue>2</issue>), <fpage>281</fpage>&#x2013;<lpage>289</lpage>. <pub-id pub-id-type="doi">10.1042/bj20120509</pub-id>
</citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oh</surname>
<given-names>S.-J.</given-names>
</name>
<name>
<surname>Ikeda</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ide</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hur</surname>
<given-names>K. Y.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>M.-S.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Mitochondrial event as an ultimate step in ferroptosis</article-title>. <source>Cell Death Discov.</source> <volume>8</volume> (<issue>1</issue>), <fpage>414</fpage>. <comment>10-08 2022</comment>. <pub-id pub-id-type="doi">10.1038/s41420-022-01199-8</pub-id>
</citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ookhtens</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kaplowitz</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>Role of the liver in interorgan homeostasis of glutathione and cyst(e)ine</article-title>. <source>Semin. Liver Dis.</source> <volume>18</volume> (<issue>4</issue>), <fpage>313</fpage>&#x2013;<lpage>329</lpage>. <pub-id pub-id-type="doi">10.1055/s-2007-1007167</pub-id>
</citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Papa</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Choy</surname>
<given-names>P. M.</given-names>
</name>
<name>
<surname>Bubici</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>The ERK and JNK pathways in the regulation of metabolic reprogramming</article-title>. <source>Oncogene</source> <volume>38</volume> (<issue>13</issue>), <fpage>2223</fpage>&#x2013;<lpage>2240</lpage>. <pub-id pub-id-type="doi">10.1038/s41388-018-0582-8</pub-id>
</citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paudel</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Hernandez</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Portalatin</surname>
<given-names>G. M.</given-names>
</name>
<name>
<surname>Chambers</surname>
<given-names>T. P.</given-names>
</name>
<name>
<surname>Chambers</surname>
<given-names>J. W.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Sab concentrations indicate chemotherapeutic susceptibility in ovarian cancer cell lines</article-title>. <source>Biochem. J.</source> <volume>475</volume> (<issue>21</issue>), <fpage>3471</fpage>&#x2013;<lpage>3492</lpage>. <pub-id pub-id-type="doi">10.1042/bcj20180603</pub-id>
</citation>
</ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qiao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Men</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Spleen tyrosine kinase promotes NLR family pyrin domain containing 3 inflammasome&#x2011;mediated IL&#x2011;1&#x3b2; secretion via c&#x2011;Jun N&#x2011;terminal kinase activation and cell apoptosis during diabetic nephropathy</article-title>. <source>Mol. Med. Rep.</source> <volume>18</volume>, <fpage>1995</fpage>. <comment>2008-14 2018</comment>. <pub-id pub-id-type="doi">10.3892/mmr.2018.9164</pub-id>
</citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qin</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>Mao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Caspase recruitment domain 6 protects against hepatic ischemia/reperfusion injury by suppressing ASK1</article-title>. <source>J. Hepatol.</source> <volume>69</volume> (<issue>5</issue>), <fpage>1110</fpage>&#x2013;<lpage>1122</lpage>. <pub-id pub-id-type="doi">10.1016/j.jhep.2018.06.014</pub-id>
</citation>
</ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rogers</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Fernandes-Alnemri</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Mayes</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Alnemri</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Cingolani</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Alnemri</surname>
<given-names>E. S.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Cleavage of DFNA5 by caspase-3 during apoptosis mediates progression to secondary necrotic/pyroptotic cell death</article-title>. <source>Nat. Commun.</source> <volume>8</volume> (<issue>1</issue>), <fpage>14128</fpage>. <comment>01-03 2017</comment>. <pub-id pub-id-type="doi">10.1038/ncomms14128</pub-id>
</citation>
</ref>
<ref id="B69">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sakaguchi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>REI-1, a novel Rab11 GEF with a SH3BP5 domain</article-title>. <source>Commun. Integr. Biol.</source> <volume>9</volume> (<issue>5</issue>), <fpage>12083255</fpage>&#x2013;<lpage>e1208402 2016</lpage>. <pub-id pub-id-type="doi">10.1080/19420889.2016.1208325</pub-id>
</citation>
</ref>
<ref id="B70">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sakaguchi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Gengyo-Ando</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yorimitsu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Nakai</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>REI-1 is a guanine nucleotide exchange factor regulating RAB-11 localization and function in <italic>C. elegans</italic> embryos</article-title>. <source>Dev. Cell</source> <volume>35</volume> (<issue>2</issue>), <fpage>211</fpage>&#x2013;<lpage>221</lpage>. <pub-id pub-id-type="doi">10.1016/j.devcel.2015.09.013</pub-id>
</citation>
</ref>
<ref id="B71">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salvi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Brunati</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Bordin</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>La Rocca</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Clari</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Toninello</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Characterization and location of Src-dependent tyrosine phosphorylation in rat brain mitochondria</article-title>. <source>Biochim. Biophys. Acta</source> <volume>1589</volume> (<issue>2</issue>), <fpage>181</fpage>&#x2013;<lpage>195</lpage>. <pub-id pub-id-type="doi">10.1016/s0167-4889(02)00174-x</pub-id>
</citation>
</ref>
<ref id="B72">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sato</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Sakaguchi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>REI/SH3BP5 protein family: new GEFs for Rab11</article-title>. <source>Cell Cycle</source> <volume>15</volume> (<issue>6</issue>), <fpage>767</fpage>&#x2013;<lpage>769</lpage>. <comment>03-18 2016</comment>. <pub-id pub-id-type="doi">10.1080/15384101.2015.1137710</pub-id>
</citation>
</ref>
<ref id="B73">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharma</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gadang</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Jaeschke</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Critical role for mixed-lineage kinase 3 in acetaminophen-induced hepatotoxicity</article-title>. <source>Mol. Pharmacol.</source> <volume>82</volume> (<issue>5</issue>), <fpage>1001</fpage>&#x2013;<lpage>1007</lpage>. <pub-id pub-id-type="doi">10.1124/mol.112.079863</pub-id>
</citation>
</ref>
<ref id="B74">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Weng</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Caspase 3/GSDME-dependent pyroptosis contributes to chemotherapy drug-induced nephrotoxicity</article-title>. <source>Cell Death Dis.</source> <volume>12</volume> (<issue>2</issue>), <fpage>186</fpage>. <comment>02-15 2021</comment>. <pub-id pub-id-type="doi">10.1038/s41419-021-03458-5</pub-id>
</citation>
</ref>
<ref id="B75">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Shao</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Pyroptosis: gasdermin-mediated programmed necrotic cell death</article-title>. <source>Trends Biochem. Sci.</source> <volume>42</volume> (<issue>4</issue>), <fpage>245</fpage>&#x2013;<lpage>254</lpage>. <pub-id pub-id-type="doi">10.1016/j.tibs.2016.10.004</pub-id>
</citation>
</ref>
<ref id="B76">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sodero</surname>
<given-names>A. O.</given-names>
</name>
<name>
<surname>Rodriguez-Silva</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Salio</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Sasso&#xe8;-Pognetto</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chambers</surname>
<given-names>J. W.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Sab is differentially expressed in the brain and affects neuronal activity</article-title>. <source>Brain Res.</source> <volume>1670</volume>, <fpage>76</fpage>&#x2013;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2017.06.005</pub-id>
</citation>
</ref>
<ref id="B77">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tadokoro</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ikeda</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ide</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Deguchi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ikeda</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Okabe</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity</article-title>. <source>JCI Insight</source> <volume>5</volume> (<issue>9</issue>), <fpage>e132747</fpage>. <comment>05-07 2020</comment>. <pub-id pub-id-type="doi">10.1172/jci.insight.132747</pub-id>
</citation>
</ref>
<ref id="B78">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takac</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Schr&#xf6;der</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Lardy</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Anilkumar</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Lambeth</surname>
<given-names>J. D.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>The E-loop is involved in hydrogen peroxide formation by the NADPH oxidase Nox4</article-title>. <source>J. Biol. Chem.</source> <volume>286</volume> (<issue>15</issue>), <fpage>13304</fpage>&#x2013;<lpage>13313</lpage>. <comment>04-01 2011</comment>. <pub-id pub-id-type="doi">10.1074/jbc.m110.192138</pub-id>
</citation>
</ref>
<ref id="B79">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takaesu</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ninomiya-Tsuji</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kishida</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Stark</surname>
<given-names>G. R.</given-names>
</name>
<name>
<surname>Matsumoto</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Interleukin-1 (IL-1) receptor-associated kinase leads to activation of TAK1 by inducing TAB2 translocation in the IL-1 signaling pathway</article-title>. <source>Mol. Cell Biol.</source> <volume>21</volume> (<issue>7</issue>), <fpage>2475</fpage>&#x2013;<lpage>2484</lpage>. <pub-id pub-id-type="doi">10.1128/mcb.21.7.2475-2484.2001</pub-id>
</citation>
</ref>
<ref id="B80">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tibaldi</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Brunati</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Massimino</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>Stringaro</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Colone</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Agostinelli</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2008</year>). <article-title>Src-Tyrosine kinases are major agents in mitochondrial tyrosine phosphorylation</article-title>. <source>J. Cell Biochem.</source> <volume>104</volume> (<issue>3</issue>), <fpage>840</fpage>&#x2013;<lpage>849</lpage>. <pub-id pub-id-type="doi">10.1002/jcb.21670</pub-id>
</citation>
</ref>
<ref id="B81">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Urano</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Bertolotti</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Harding</surname>
<given-names>H. P.</given-names>
</name>
<etal/>
</person-group> (<year>2000</year>). <article-title>Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1</article-title>. <source>Science</source> <volume>287</volume> (<issue>5453</issue>), <fpage>664</fpage>&#x2013;<lpage>666</lpage>. <pub-id pub-id-type="doi">10.1126/science.287.5453.664</pub-id>
</citation>
</ref>
<ref id="B82">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>P. X.</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>Y. X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X. J.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>L. P.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>Z. Z.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>P.</given-names>
</name>
<etal/>
</person-group> (<year>2017a</year>). <article-title>Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates</article-title>. <source>Nat. Med.</source> <volume>23</volume> (<issue>4</issue>), <fpage>439</fpage>&#x2013;<lpage>449</lpage>. <pub-id pub-id-type="doi">10.1038/nm.4290</pub-id>
</citation>
</ref>
<ref id="B83">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2017b</year>). <article-title>Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin</article-title>. <source>Nature</source> <volume>547</volume> (<issue>7661</issue>), <fpage>99</fpage>&#x2013;<lpage>103</lpage>. <pub-id pub-id-type="doi">10.1038/nature22393</pub-id>
</citation>
</ref>
<ref id="B84">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weijman</surname>
<given-names>J. F.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Jamieson</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>King</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Caradoc-Davies</surname>
<given-names>T. T.</given-names>
</name>
<name>
<surname>Ledgerwood</surname>
<given-names>E. C.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Structural basis of autoregulatory scaffolding by apoptosis signal-regulating kinase 1</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>114</volume> (<issue>11</issue>), <fpage>E2096</fpage>&#x2013;<lpage>e2105</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1620813114</pub-id>
</citation>
</ref>
<ref id="B85">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Willingham</surname>
<given-names>S. B.</given-names>
</name>
<name>
<surname>Bergstralh</surname>
<given-names>D. T.</given-names>
</name>
<name>
<surname>O&#x27;Connor</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Morrison</surname>
<given-names>A. C.</given-names>
</name>
<name>
<surname>Taxman</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Duncan</surname>
<given-names>J. A.</given-names>
</name>
<etal/>
</person-group> (<year>2007</year>). <article-title>Microbial pathogen-induced necrotic cell death mediated by the inflammasome components CIAS1/cryopyrin/NLRP3 and ASC</article-title>. <source>Cell Host Microbe</source> <volume>2</volume> (<issue>3</issue>), <fpage>147</fpage>&#x2013;<lpage>159</lpage>. <comment>09-01 2007</comment>. <pub-id pub-id-type="doi">10.1016/j.chom.2007.07.009</pub-id>
</citation>
</ref>
<ref id="B86">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wiltshire</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Matsushita</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tsukada</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gillespie</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>May</surname>
<given-names>G. H.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>A new c-Jun N-terminal kinase (JNK)-interacting protein, Sab (SH3BP5), associates with mitochondria</article-title>. <source>Biochem. J.</source> <volume>367</volume> (<issue>Pt 3</issue>), <fpage>577</fpage>&#x2013;<lpage>585</lpage>. <pub-id pub-id-type="doi">10.1042/bj20020553</pub-id>
</citation>
</ref>
<ref id="B87">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Win</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Min</surname>
<given-names>R. W.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C. Q.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Expression of mitochondrial membrane-linked SAB determines severity of sex-dependent acute liver injury</article-title>. <source>J. Clin. Invest</source> <volume>129</volume> (<issue>12</issue>), <fpage>5278</fpage>&#x2013;<lpage>5293</lpage>. <pub-id pub-id-type="doi">10.1172/jci128289</pub-id>
</citation>
</ref>
<ref id="B88">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Win</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Min</surname>
<given-names>R. W. M.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kanel</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Wanken</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Hepatic mitochondrial SAB deletion or knockdown alleviates diet-induced metabolic syndrome, steatohepatitis, and hepatic fibrosis</article-title>. <source>Hepatology</source> <volume>74</volume> (<issue>6</issue>), <fpage>3127</fpage>&#x2013;<lpage>3145</lpage>. <pub-id pub-id-type="doi">10.1002/hep.32083</pub-id>
</citation>
</ref>
<ref id="B89">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Win</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Than</surname>
<given-names>T. A.</given-names>
</name>
<name>
<surname>Fernandez-Checa</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Kaplowitz</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>JNK interaction with Sab mediates ER stress induced inhibition of mitochondrial respiration and cell death</article-title>. <source>Cell Death Dis.</source> <volume>5</volume> (<issue>1</issue>), <fpage>e989</fpage>. <pub-id pub-id-type="doi">10.1038/cddis.2013.522</pub-id>
</citation>
</ref>
<ref id="B90">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Win</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Than</surname>
<given-names>T. A.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Petrovic</surname>
<given-names>L. M.</given-names>
</name>
<name>
<surname>Kaplowitz</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>c-Jun N-terminal kinase (JNK)-dependent acute liver injury from acetaminophen or tumor necrosis factor (TNF) requires mitochondrial Sab protein expression in mice</article-title>. <source>J. Biol. Chem.</source> <volume>286</volume> (<issue>40</issue>), <fpage>35071</fpage>&#x2013;<lpage>35078</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M111.276089</pub-id>
</citation>
</ref>
<ref id="B91">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Win</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Than</surname>
<given-names>T. A.</given-names>
</name>
<name>
<surname>Kaplowitz</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2018b</year>). <article-title>The regulation of JNK signaling pathways in cell death through the interplay with mitochondrial SAB and upstream post-translational effects</article-title>. <source>Int. J. Mol. Sci.</source> <volume>19</volume> (<issue>11</issue>), <fpage>3657</fpage>. <pub-id pub-id-type="doi">10.3390/ijms19113657</pub-id>
</citation>
</ref>
<ref id="B92">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Win</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Than</surname>
<given-names>T. A.</given-names>
</name>
<name>
<surname>Kaplowitz</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>c-Jun-N terminal kinase-mediated degradation of &#x3b3;-glutamylcysteine ligase catalytic subunit inhibits GSH recovery after acetaminophen treatment: role in sustaining JNK activation and liver injury</article-title>. <source>Antioxid. Redox Signal</source> <volume>38</volume> (<issue>16-18</issue>), <fpage>1071</fpage>&#x2013;<lpage>1081</lpage>. <pub-id pub-id-type="doi">10.1089/ars.2022.0119</pub-id>
</citation>
</ref>
<ref id="B93">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Win</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Than</surname>
<given-names>T. A.</given-names>
</name>
<name>
<surname>Le</surname>
<given-names>B. H.</given-names>
</name>
<name>
<surname>Garc&#xed;a-Ruiz</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Fernandez-Checa</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Kaplowitz</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Sab (Sh3bp5) dependence of JNK mediated inhibition of mitochondrial respiration in palmitic acid induced hepatocyte lipotoxicity</article-title>. <source>J. Hepatol.</source> <volume>62</volume> (<issue>6</issue>), <fpage>1367</fpage>&#x2013;<lpage>1374</lpage>. <pub-id pub-id-type="doi">10.1016/j.jhep.2015.01.032</pub-id>
</citation>
</ref>
<ref id="B94">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Win</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Than</surname>
<given-names>T. A.</given-names>
</name>
<name>
<surname>Min</surname>
<given-names>R. W.</given-names>
</name>
<name>
<surname>Aghajan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kaplowitz</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>c-Jun N-terminal kinase mediates mouse liver injury through a novel Sab (SH3BP5)-dependent pathway leading to inactivation of intramitochondrial Src</article-title>. <source>Hepatology</source> <volume>63</volume> (<issue>6</issue>), <fpage>1987</fpage>&#x2013;<lpage>2003</lpage>. <pub-id pub-id-type="doi">10.1002/hep.28486</pub-id>
</citation>
</ref>
<ref id="B95">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Win</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Than</surname>
<given-names>T. A.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Oo</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Min</surname>
<given-names>R. W. M.</given-names>
</name>
<name>
<surname>Kaplowitz</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2018a</year>). <article-title>New insights into the role and mechanism of c-Jun-N-terminal kinase signaling in the pathobiology of liver diseases</article-title>. <source>Hepatology</source> <volume>67</volume> (<issue>5</issue>), <fpage>2013</fpage>&#x2013;<lpage>2024</lpage>. <pub-id pub-id-type="doi">10.1002/hep.29689</pub-id>
</citation>
</ref>
<ref id="B96">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Ferroptosis in liver disease: new insights into disease mechanisms</article-title>. <source>Cell Death Discov.</source> <volume>7</volume> (<issue>1</issue>), <fpage>276</fpage>. <comment>10-05 2021</comment>. <pub-id pub-id-type="doi">10.1038/s41420-021-00660-4</pub-id>
</citation>
</ref>
<ref id="B97">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xia</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Magupalli</surname>
<given-names>V. G.</given-names>
</name>
<name>
<surname>Pablo</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Vora</surname>
<given-names>S. M.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Gasdermin D pore structure reveals preferential release of mature interleukin-1</article-title>. <source>Nature</source> <volume>593</volume> (<issue>7860</issue>), <fpage>607</fpage>&#x2013;<lpage>611</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-021-03478-3</pub-id>
</citation>
</ref>
<ref id="B98">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xie</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Ferroptosis: process and function</article-title>. <source>Cell Death Differ.</source> <volume>23</volume> (<issue>3</issue>), <fpage>369</fpage>&#x2013;<lpage>379</lpage>. <comment>03-01 2016</comment>. <pub-id pub-id-type="doi">10.1038/cdd.2015.158</pub-id>
</citation>
</ref>
<ref id="B99">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yan</surname>
<given-names>H.-F.</given-names>
</name>
<name>
<surname>Zou</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tuo</surname>
<given-names>Q. Z.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Belaidi</surname>
<given-names>A. A.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Ferroptosis: mechanisms and links with diseases</article-title>. <source>Signal Transduct. Target. Ther.</source> <volume>6</volume> (<issue>1</issue>), <fpage>49</fpage>. <comment>02-03 2021</comment>. <pub-id pub-id-type="doi">10.1038/s41392-020-00428-9</pub-id>
</citation>
</ref>
<ref id="B100">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Pyroptosis: mechanisms and diseases</article-title>. <source>Signal Transduct. Target. Ther.</source> <volume>6</volume> (<issue>1</issue>), <fpage>128</fpage>. <comment>03-29 2021</comment>. <pub-id pub-id-type="doi">10.1038/s41392-021-00507-5</pub-id>
</citation>
</ref>
<ref id="B101">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuan</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Kaplowitz</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Glutathione in liver diseases and hepatotoxicity</article-title>. <source>Mol. Asp. Med.</source> <volume>30</volume> (<issue>1-2</issue>), <fpage>29</fpage>&#x2013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1016/j.mam.2008.08.003</pub-id>
</citation>
</ref>
<ref id="B102">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeke</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Misheva</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rem&#xe9;nyi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bogoyevitch</surname>
<given-names>M. A.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>JNK signaling: regulation and functions based on complex protein-protein partnerships</article-title>. <source>Microbiol. Mol. Biol. Rev.</source> <volume>80</volume> (<issue>3</issue>), <fpage>793</fpage>&#x2013;<lpage>835</lpage>. <pub-id pub-id-type="doi">10.1128/mmbr.00043-14</pub-id>
</citation>
</ref>
<ref id="B103">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Min</surname>
<given-names>R. W. M.</given-names>
</name>
<name>
<surname>Le</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Aghajan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Than</surname>
<given-names>T. A.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>The role of MAP2 kinases and p38 kinase in acute murine liver injury models</article-title>. <source>Cell Death Dis.</source> <volume>8</volume> (<issue>6</issue>), <fpage>e2903</fpage>. <pub-id pub-id-type="doi">10.1038/cddis.2017.295</pub-id>
</citation>
</ref>
<ref id="B104">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>P. X.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>L. P.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>Y. X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X. J.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis</article-title>. <source>Nat. Med.</source> <volume>24</volume> (<issue>1</issue>), <fpage>84</fpage>&#x2013;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1038/nm.4453</pub-id>
</citation>
</ref>
<ref id="B105">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Al-Lamki</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bai</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Streb</surname>
<given-names>J. W.</given-names>
</name>
<name>
<surname>Miano</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Bradley</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2004</year>). <article-title>Thioredoxin-2 inhibits mitochondria-located ASK1-mediated apoptosis in a JNK-independent manner</article-title>. <source>Circ. Res.</source> <volume>94</volume> (<issue>11</issue>), <fpage>1483</fpage>&#x2013;<lpage>1491</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.0000130525.37646.a7</pub-id>
</citation>
</ref>
<ref id="B106">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Q.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Caspase&#x2010;3&#x2010;mediated GSDME induced Pyroptosis in breast cancer cells through the ROS/JNK signalling pathway</article-title>. <source>J. Cell. Mol. Med.</source> <volume>25</volume> (<issue>17</issue>), <fpage>8159</fpage>&#x2013;<lpage>8168</lpage>. <comment>09-01 2021</comment>. <pub-id pub-id-type="doi">10.1111/jcmm.16574</pub-id>
</citation>
</ref>
<ref id="B107">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Gasdermin E suppresses tumour growth by activating anti-tumour immunity</article-title>. <source>Nature</source> <volume>579</volume> (<issue>7799</issue>), <fpage>415</fpage>&#x2013;<lpage>420</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-020-2071-9</pub-id>
</citation>
</ref>
<ref id="B108">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells</article-title>. <source>Science</source> <volume>368</volume>, <fpage>6494</fpage>. <pub-id pub-id-type="doi">10.1126/science.aaz7548</pub-id>
</citation>
</ref>
</ref-list>
<sec id="s11">
<title>Glossary</title>
<table-wrap id="udT1" position="float">
<table>
<tbody valign="top">
<tr>
<td align="left">
<bold>AP-1</bold>
</td>
<td align="left">activating protein-1</td>
</tr>
<tr>
<td align="left">
<bold>APAP</bold>
</td>
<td align="left">acetaminophen</td>
</tr>
<tr>
<td align="left">
<bold>ASK1</bold>
</td>
<td align="left">apoptosis signal-regulating kinase 1</td>
</tr>
<tr>
<td align="left">
<bold>AMPK</bold>
</td>
<td align="left">AMP-activated kinase</td>
</tr>
<tr>
<td align="left">
<bold>BCL2</bold>
</td>
<td align="left">B-cell lymphoma 2</td>
</tr>
<tr>
<td align="left">
<bold>CARD6</bold>
</td>
<td align="left">caspase recruitment domain protein 6</td>
</tr>
<tr>
<td align="left">
<bold>cFLIP</bold>
</td>
<td align="left">cellular FLICE-like inhibitory protein</td>
</tr>
<tr>
<td align="left">
<bold>CRLS1</bold>
</td>
<td align="left">cardiolipin synthase 1</td>
</tr>
<tr>
<td align="left">
<bold>ER</bold>
</td>
<td align="left">endoplasmic reticulum</td>
</tr>
<tr>
<td align="left">
<bold>GalN</bold>
</td>
<td align="left">galactosamine</td>
</tr>
<tr>
<td align="left">
<bold>GSH</bold>
</td>
<td align="left">glutathione</td>
</tr>
<tr>
<td align="left">
<bold>GSDM</bold>
</td>
<td align="left">gasdermin</td>
</tr>
<tr>
<td align="left">
<bold>GTPases</bold>
</td>
<td align="left">guanosine triphosphate hydrolase</td>
</tr>
<tr>
<td align="left">
<bold>IMM</bold>
</td>
<td align="left">inner mitochondrial membrane</td>
</tr>
<tr>
<td align="left">
<bold>ITCH</bold>
</td>
<td align="left">itchy E3 ubiquitin protein ligase</td>
</tr>
<tr>
<td align="left">
<bold>JIP</bold>
</td>
<td align="left">JNK-interacting protein</td>
</tr>
<tr>
<td align="left">
<bold>JNK</bold>
</td>
<td align="left">c-Jun NH2-terminal kinase</td>
</tr>
<tr>
<td align="left">
<bold>KIM</bold>
</td>
<td align="left">kinase interaction motif</td>
</tr>
<tr>
<td align="left">
<bold>LPS</bold>
</td>
<td align="left">lipopolysaccharide</td>
</tr>
<tr>
<td align="left">
<bold>MAPK</bold>
</td>
<td align="left">mitogen-activated protein kinase</td>
</tr>
<tr>
<td align="left">
<bold>MASH</bold>
</td>
<td align="left">metabolic dysfunction-associated steatohepatitis</td>
</tr>
<tr>
<td align="left">
<bold>MEF</bold>
</td>
<td align="left">mouse embryonic fibroblast</td>
</tr>
<tr>
<td align="left">
<bold>Mito-TEMPO</bold>
</td>
<td align="left">mitochondria-targeted antioxidant</td>
</tr>
<tr>
<td align="left">
<bold>MLK</bold>
</td>
<td align="left">mixed lineage kinase</td>
</tr>
<tr>
<td align="left">
<bold>MMP</bold>
</td>
<td align="left">mitochondrial membrane potential</td>
</tr>
<tr>
<td align="left">
<bold>MPTP</bold>
</td>
<td align="left">mitochondrial permeability transition pore</td>
</tr>
<tr>
<td align="left">
<bold>NADPH</bold>
</td>
<td align="left">nicotinamide adenine dinucleotide phosphate hydrogen</td>
</tr>
<tr>
<td align="left">
<bold>NCC</bold>
</td>
<td align="left">N-terminal coiled-coil</td>
</tr>
<tr>
<td align="left">
<bold>NCoR1</bold>
</td>
<td align="left">nuclear receptor corepressor 1</td>
</tr>
<tr>
<td align="left">
<bold>NLRP3</bold>
</td>
<td align="left">NLR family pyrin domain containing 3</td>
</tr>
<tr>
<td align="left">
<bold>OMM</bold>
</td>
<td align="left">outer mitochondrial membrane</td>
</tr>
<tr>
<td align="left">
<bold>PLSCR3</bold>
</td>
<td align="left">phospholipid scramblase 3</td>
</tr>
<tr>
<td align="left">
<bold>PPAR&#x3b1;</bold>
</td>
<td align="left">peroxisome proliferator-activated receptor alpha</td>
</tr>
<tr>
<td align="left">
<bold>PUMA</bold>
</td>
<td align="left">p53-upregulated modulator of apoptosis</td>
</tr>
<tr>
<td align="left">
<bold>RAB-11</bold>
</td>
<td align="left">Ras-related GTP-binding protein Rab11</td>
</tr>
<tr>
<td align="left">
<bold>RAC</bold>
</td>
<td align="left">Ras-related C3 botulinum toxin substrate</td>
</tr>
<tr>
<td align="left">
<bold>REI-1</bold>
</td>
<td align="left">guanine nucleotide exchange factor rei-1</td>
</tr>
<tr>
<td align="left">
<bold>ROS</bold>
</td>
<td align="left">reactive oxygen species</td>
</tr>
<tr>
<td align="left">
<bold>SAB</bold>
</td>
<td align="left">SH3BP5</td>
</tr>
<tr>
<td align="left">
<bold>SOD2</bold>
</td>
<td align="left">superoxide dismutase 2</td>
</tr>
<tr>
<td align="left">
<bold>SRC</bold>
</td>
<td align="left">proto-oncogene tyrosine-protein kinase Src</td>
</tr>
<tr>
<td align="left">
<bold>TAK1</bold>
</td>
<td align="left">transforming growth factor-&#x3b2; (TGF-&#x3b2;)-activated kinase 1</td>
</tr>
<tr>
<td align="left">
<bold>TNF</bold>
</td>
<td align="left">tumor necrosis factor</td>
</tr>
<tr>
<td align="left">
<bold>TRAF</bold>
</td>
<td align="left">tumor necrosis factor receptor-associated factor</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
</back>
</article>